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COORDINATION CHEMISTRY OF N,N’-AZODIOXIDES 
LAKSHMI BALARAMAN 
ABSTRACT  
INTRODUCTION  
The coordination chemistry of nitric oxide (NO) with transition metals has been extensively 
investigated, but that of organic NO derivatives as ligands less so. Some nitrosoalkanes RNO and 
nitrosoarenes ArNO are in equilibrium with dimeric species known as N,N´–azodioxides, 
R(O)NN(O)R or Ar(O)NN(O)Ar. The cis diastereomers of azodioxides have been proposed to act 
as bidentate chelating ligands for both main-group and transition metals, but only three azodioxide 
complexes, a dicationic iron (II) complex, a neutral scandium (III) complex, and a dicationic 
calcium (II) complex, have thus far been structurally characterized before our work in this area. 
The delocalized π system of azodioxides suggests that they may be able to act as redox-active 
ligands. The objectives of this project are to develop further the coordination chemistry of 
azodioxides and to investigate their ability to behave as redox-active ligands.  The first goal is the 
synthesis and characterization of novel azodioxide complex cations of first-row transition metals, 
with the diamagnetic, redox-stable counteranion hexaflurophosphate (PF6
-). This synthetic 
strategy has yielded novel azodioxide complexes of cobalt whose structure was determined via 
single-crystal X-ray diffraction. Future work will involve spectroscopic and magnetic 
measurements of azodioxide complexes for evidence of electroisomerism, a phenomenon 
characterized by low-lying, thermally accessible electronic excited states arising from metal-to-
ligand or ligand-to-metal charge transfer. Additionally, azodioxide complexes will be screened as 
potential catalysts for organic reactions such as allylic amination/ reactions of alkenes. Medicinal 
applications of azodioxides will also be explored by cell-based studies on cancer cells.  
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CENTRAL HYPOTHESIS  
We hypothesized the coordination geometry of the cobalt azodioxide complex to be trigonal 
prismatic with a coordination number of 6. We hypothesized that the synthesized cobalt azodioxide 
complex can display ligand-based redox activity. The cobalt azodioxide complex was also 
proposed to be a catalyst in allylic amination. It was also hypothesized that the cobalt azodioxide 
complex would kill cancer cells by apoptosis.   
RESULTS  
We found that the coordination geometry of the cobalt azodioxide complex was tetragonal and 
the coordination number was 8. This is rare for cobalt complexes. Only 4 other monometallic 
cobalt (II) complexes with this coordination number have been reported.  
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CHAPTER I 
INTRODUCTION 
 An important motivation of this research project is catalysis in the area of drug 
development Catalysis has become progressively pivotal for the pharmaceutical industry. 
Catalysis is a chemical phenomenon exploited in many forms of technology that implements 
environmental, economical, and manufacturing processes1. The use of catalysis has been lucrative 
for Active Pharmaceutical Ingredient (API) synthesis. Pharmaceutical research and development 
(R&D) processes have evaluated the cost of bringing a drug to the as roughly $2 billion1, 2. The 
complicated structure of APIs, multiple diverse reaction types used for synthesis, and difficult 
product isolation and purification necessitates the standardization of the drug development 
process.  Therefore, catalysis becomes helpful for faster and more economical reactions2. Statistics 
show that 90% of pharmaceuticals are acquired from catalytic processes3.Themarket value of 
products achieved via catalysis has attained about $900 billion per annum4.  
1.1 Types of catalysis 
  There are two fundamental types of catalysts, homogeneous and heterogeneous. 
Homogeneous catalysts are present in the same phase as the reactants, while heterogeneous 
catalysts are present in a different phase. 
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 Examples of homogeneous and heterogeneous catalysis include many examples of acid catalysis, 
and organometallic catalysis 5. A specific example of heterogeneous catalysis is the hydrogenation 
of alkenes in solution by hydrogen gas, catalyzed by finely ground Ni, Pd or Pt, over which the 
reaction mixture is stirred5.  
1.2 Transition-metal catalysis 
  Metal catalysts can participate in different reaction pathways that accelerate the bond 
breakage and bond formation required for the net reaction. A transition metal atom has s, p, and d 
valence atomic orbitals that are energetically and geometrically applicable for bonding with 
ligands7.  
1.3 Allylic amination 
Allylic amination is an important organic reaction known to be catalyzed by transition 
metal complexes.  Details of this reaction will be discussed further in future chapters.  
There exist useful drugs that contain allylic amines as functional groups. Some examples of such 
drugs are shown in Figures 1, 2, 3, and 4. 
 
 
Figure 1: Structure of Nafitifine (antifungal drug) 10 
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Figure 2: Structure of Terbinafine (antifungal drug) 11 
                                                           
Figure 3: Structure of Flunarizine (migraine treatment) 12 
4 
 
 
Figure 4: Structure of Cinnarizine (calcium channel blocker drug) 13 
1.4 Biological applications of transition metals 
Cobalt is an important part of vitamin B12 (it is coordinated in the center of the prosthetic 
corrin ring), which is necessary for the metabolism of folic acid and fatty acids14. Cobalt complexes 
have been found to have antibacterial properties14.  Cobalt is also present in non-corrin containing 
enzymes, such as methionine aminopeptidase, prolidase, nitrile hydratase, glucose isomerase, 
methylmalonyl‐CoA carboxytransferase, aldehyde decarbonylase, lysine‐2, 3‐aminomutase, and 
bromoperoxidase14.  
  Iron in hemoglobin binds with oxygen and releases it in tissues. Myoglobin is another iron-
containing protein.15. It carries oxygen to the muscles, and is thus important for cellular activity of 
all tissues. Iron is required for cell division, cell growth, and protein metabolism15.    
   Nickel can affect the enzymes involved in nucleic acid synthesis16. Nickel is linked with 
proteins that affect the breakdown of glucose. 
  Nickel is useful in the creation and activity of some hormones, 17 and nickel-based enzyme 
systems play a crucial role in carbon, nitrogen, and oxygen cycles. Nickel is required for the 
biosynthesis of hydrogenase, and carbon monoxide dehydrogenase found in bacteria17. 
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Copper is a crucial part of many enzymes which have activity in the heart, brain, liver, and 
kidney. Copper is essential for the development and preservation of blood vessels, bones, joints, 
and skin.18 Copper is important in immune response, because it is needed for the maturation and 
function of T cells.19 Copper also plays a role in mitochondrial, hepatocyte, and neuronal functions 
1. 5 Nitric oxide (NO)  
NO has a significant role in biological processes such as vasodilation and immune 
response21.The main targets for NO under bioregulatory conditions are metal centers (primarily 
iron) in metalloproteins. Nitrosyl complex (NO acting as a ligand for a metal) formation with the 
heme group causes the labilization of a proximal histidine ligand in the protein backbone21. The 
resultant change in protein conformation activates the enzyme for the catalytic formation of cyclic 
guanylyl monophosphate (cGMP) from guanylyl triphosphate (GTP) is one example of an NO-
activated metalloenzyme namely soluble guanylate cyclase (SGc) 22.  
  The relaxation of blood vessels in smooth muscles is due to the enzymatic formation of 
cGMP22. This relaxation causes a lowering in blood pressure. Continuous production of NO 
enables macrophages to display cytostatic or cytotoxic activity against bacteria and tumor cells23. 
NO is an inhibitor for metalloenzymes like cytochrome P450, 
cytochrome oxidase and catalase. NO acts as a substrate for mammalian peroxidases23. Heme 
centers play a role in the in vivo generation of NO by oxidation of arginine, catalyzed 
by nitric oxide synthase (NOS) enzymes24.  NO plays a role in reperfusion injury via its reaction 
with the superoxide radical anion (O2
-) to form peroxynitrite (ONOO-). (Reperfusion injury is 
tissue damage caused due to the return of blood supply after a period of shortage of oxygen) 25.  
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Protonation of peroxynitrite forms peroxynitrous acid (ONOOH), which decomposes to 
form the toxic free radical species nitrogen dioxide (NO2) and hydroxyl (OH)
 25, as shown in Figure 
5. 
 
  
Figure 5: Formation of peroxynitrite and toxic radical species25 
1. Nitric oxide and the central nervous system: NO has a significant effect on the central nervous 
system. It is one of the main neurotransmitters26. NO is synthesized only when necessary because 
it is a gas and the reactivity of NO with so many molecules and thus, NO is not stored in vessels 
in large quantities within living cells. After the synthesis, NO is swiftly diffused to neighboring 
neurons26.  NO can have neuromodulatory, neuroprotective, or neurotoxic activity, depending on 
the situation26.  
2. Nitric oxide and the cardiovascular system: The role of NO in the cardiovascular system is 
of high importance in clinical cardiology research 27. Drugs that release NO are effective in 
prevention and treatment of ischemic heart disease27. NO has vasodilatory effects. NO is generated 
predominantly by the endothelial isoform of NOS (eNOS)27. Blood regulation and blood flow are 
controlled by basal release of NO from L- arginine. 
3. NO and the respiratory system: Inhibition of smooth muscle contraction in airways is due to 
the positive exogenous and endogenous effects of NO28.  
Bronchomotor tonus regulation is the major function of NO in airways. Some of the other 
functions of NO in the respiratory system are bronchodilation of airway smooth muscle, increase 
in rate of ciliary beat and decrease in mucus viscosity in the epithelium28. 
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4. NO and the gastrointestinal system:  NO works as a neurotransmitter in the gastrointestinal 
system29. It is released by the peripheral nervous system.  NO was found in the myenteric plexus 
of stomach, intestines, and the lower esophageal organs29. NO causes regulation of peristalsis and 
stimulation of mucus secretion into the gut29. 
1.6 Nitrosyl ligands 
The oxidation of NO forms the nitrosonium cation (NO+), and the reduction of NO forms the 
nitrosyl anion (NO-), 30 as shown in Figure 6. 
 
 
  
 
Figure 6: Formation of nitosonium (cation) and nitrosyl(anion)30 
In metal complexes the nitrosonium cation and anion can serve as ligands to form metal-
nitrosyl complexes.30 NO+ and NO- are considered as 2e donors. (ionic counting method)31 
However, when the NO ligand is considered neutral(neutral counting method), NO+ coordinates 
in the linear form (3e donor) and the NO- coordinates in the bent fashion (1e donor)31. 
The metal to nitrosyl ligand bonding of both the forms 32 is shown in Figure 7. 
 
Linear form                                          Bent form    
Figure 7: Bent and linear forms of the nitrosyl ligand32 
Many organic derivatives of nitric oxide are known, including nitrosoalkanes RNO and 
nitrosoarenes ArNO33. Nitrosoalkanes are often unstable34. Those nitrosoalkanes with hydrogen 
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atoms α to the nitroso group undergo tautomerization to their oxime isomers34.The equilibrium 
strongly favors the oxime tautomer, as shown for nitrosomethane in Figure 834. 
 
Figure 8: Tautomerization of nitrosomethane to formaldoxime34 
Some nitrosoalkanes and nitrosoarenes undergo dimerization to form N, N´–azodioxides 
35 as shown in Figure 9. 
 
Figure 9: Dimerization of nitrosoalkanes and nitrosoarenes to N, N’-azodioxides 35 
Nitrosobenzene preferentially forms the cis azodioxide when it dimerizes35 Cis-
azodioxides have the ability to act as bidentate chelating ligand which makes the cis form 
interesting35. Chelating ligands can bind to a metal via more than one Lewis-basic atom. 
Chelating ligands are significant in terms of kinetics and thermodynamics.36. A thermodynamic 
analysis shows that the so-called chelate effect is mainly entropy-driven 36 .Due to entropic 
reasons chelating ligands bind metals more strongly compared to electronically similar 
monodentate ligands. For the kinetic effect, the replacement of a chelating ligand with two 
monodentate ligands is slower compared to the replacement of a pair of electronically analogous 
monodentate ligands36.   
The resonance structures of cis-azodioxides are shown in Figure 1037 .The N-N and N-O bond 
lengths are constant with considerable π delocalization37.  (N-N bond length is 1.32 Å and the N-
O bond length is 1.27 Å). ligands37.             
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Figure 10: Resonance structures of cis-Ph(O)NN(O)Ph 37 
1.7 Previous work 
The first crystallographically characterized azodioxide complex reported is 
[Fe{ Ph(O)NN(O)Ph}3](FeCl4)2
38 .The synthesis of this compound was accomplished using iron 
(II) chloride and nitrosobenzene by Nicholas et al38. In this reaction there is the presence of Fe 
(II) and Fe (III) in the product with Fe (II) in the azodioxide complex cation and Fe (III) in the 
anion, because of the oxidation of some Fe (II) to Fe (III) by nitrosobenzene or its azodioxide 
dimer. This reaction is shown below in Figure 1138. 
 
Figure 11: Synthesis of [Fe{κ2-O,O´-Ph(O)NN(O)Ph}3][FeCl4]2 by Nicholas and co-workers38 
Proposed balanced equation for Nicholas’s reaction 
Nicholas and co-workers found organic by products-azoxybenzene (PhNN(O)Ph) and 
azobenzene (PhNNPh) by GC-MS38. Figure 12 shows a proposed balanced equation for the 
synthesis of [Fe{Ph(O)NN(O)Ph}3](FeCl4)2 with partial deoxygenation of nitrosobenzene or its 
dimer to azoxybenzene38. Full deoxygenation produces azobenzene. 
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Figure 12: Proposed balanced equation for the formation of 
[Fe {κ2-O, O´-Ph (O) NN (O) Ph}3][FeCl4]2 showing all the side products38 
The coordination geometry of [Fe{Ph(O)NN(O)Ph}3](FeCl4)2 , is roughly trigonal 
prismatic38, compared to the common octahedral coordination geometry of complexes with a 
coordination number of 6. This geometry can be rationalized in 
 terms of the isolobal analogy39a. This is because cis azodioxides are isolobal with dithiolene 
dianions 39b R2C2S2 
2-.  The N-N and N-O bond lengths are akin to free cis -Ph(O)NN(O)Ph36. 
The mean N-N and N-O bond lengths are- 1.29 and 1.28 Å respectively38. The mean metal to 
oxygen (Fe- O) bond length is 2.12 Å. The chelate rings are roughly planar 38 . 
Nicholas and co-workers showed that [Fe{Ph(O)NN(O)Ph}3](FeCl4)2 was a competent catalyst 
for C-C double bond transposition/allylic amination reaction, as shown in Figure 1340 
 
Figure 13: Allylic amination/C- C double bond transposition of amines catalyzed by Nicholas’s 
complex40  
 
The partial catalytic cycle for the above reaction, proposed by Nicholas and co-workers, is 
shown in Figure 1440. 
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Figure 14: Proposed catalytic cycle for the allylic amination reaction  
In pathway a there is an initial direct attack by an N atom of the coordinated azodioxide  
ligand on the alkene substrate in a nitroso-ene reaction to form an allylhydroxyl amine complex, 
indicated by 5 in the catalytic cycle40. Dissociation of allylhydroxylamine from Fe is followed by 
deoxygenation by an Fe (II) species. Pathways b and c operate by different mechanisms. The 
dechelation of azodioxide ligand forms a five- coordinate intermediate 6 which would (in step b) 
coordinate alkene giving the adduct 3; migration of the PhNO unit of 3 to the alkene would 
produce allylhydroxylamine, which is finally reduced40. Alternately, intermediate 6 could 
transfer an RNO unit directly to alkene in an ene reaction without alkene coordination (pathway 
c) .Mechanism b is favored because a negligible entropy of activation ΔS‡ based on kinetic   
measurements40. 
 
 
 
12 
 
Another example of a metal azodioxide complex that has been characterized is 
Sc(OSO2CF3)3(H2O)2{Ar(O)NN(O)Ar}  Ar=2-OMeC6H4 by Whiting et al 
41. This complex is an 
example of a d0 (no valence d electrons) complex. The reaction scheme is shown in Figure 1541 
 
Figure 15: Synthesis of Sc(OSO2CF3)3(H2O)2{Ar(O)NN(O)Ar} by Whiting and co-workers
41 
The Sc(OSO2CF3)3(H2O)2{Ar(O)NN(O)Ar}is a 7- coordinate complex. The mean N-N 
and the N-O bond lengths, determined by x-ray crystallography, are 1.29 and 1.28 Å41.  
The mean scandium to oxygen bond length determined by x- ray crystallography is - 2.21 Å41.  
Sc(OSO2CF3)3(H2O)2{Ar(O)NN(O)Ar} serves as an effective source of ArNO as a dienophile 
for the Diels-Alder reaction41. This is different from the allylic amination catalyzed by Nicholas 
and co-workers, as there is no involvement of free PhNO as an intermediate40. The catalytic 
cycle for the reaction catalyzed by Sc(OSO2CF3)3(H2O)2{Ar(O)NN(O)Ar} is shown in Figure 
16.    
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Figure 16: Catalytic cycle for the Scandium (III) triflate catalyzed reaction 41  
Sc(OSO2CF3)3(H2O)2{Ar(O)NN(O)Ar} was treated with cyclohexadiene which led to the 
formation of cycloadduct 2. It is seen that the scandium complex does not hinder with the 
cycloaddition reaction of 1 and 241.  
The scandium complex also does not increase or decrease the reaction rate, which indicates that 
Lewis acids do not affect the rate of arylnitroso cycloaddition with cyclohexadiene41.  
There is a rapid equilibrium that is present between the dimer 4 and the scandium complex41.  
Therefore, the rate determining step is the thermal cycloaddition reaction step.  
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A third example of a metal azodioxide complex is [Ca{Ph(O)NN(O)Ph}(H2O)2(THF)3]I2  
synthesized by Young et al 42 . Calcium is a main- group element, and thus no valence d 
electrons are present in this complex. The reaction scheme is shown in Figure 17 42. 
 
              
Figure 17: Synthesis of [Ca{Ph(O)NN(O)Ph}(H2O)2(THF)3]I2 by Young and co-workers.  
The coordination number of the calcium complex is 7 (indicated by the X-ray crystal 
structure).  The mean N-N, N-O bonds, and the Ca-O bonds were determined by X-ray 
crystallography. The mean N-N and N-O bond lengths are-1.30 and 1.37 Å42. The mean Ca-O 
bond length is 2.42 Å42. There has been no catalytic activity reported for this compound. 
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CHAPTER II 
REDOX- ACTIVITY 
A redox-active (or “non-innocent”) ligand is a ligand in whose complexes it can be 
difficult to predict the oxidation state of the metal, as more than one assignment of ligand charge 
is plausible43. Some examples of redox- active ligands are shown in Figure 18, Figure 19, and 
Figure 20 respectively. 
 
 
Figure 18: Structure of 2, 2-bipyridyl44 
 
 
Figure 19: Structure of 1, 10-phenanthroline45 
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Figure 20: Structure of 3, 5-di-tert-butylcatecholate46 
Ligand redox activity has been demonstrated by the Pierpont group46 in cobalt complexes 
of the dianionic 3, 5-di-tert-butylcatecholate (3, 5-DBCat) ligand, which upon one electron 
oxidation is converted to the radical monoanion 3, 5-di- tert butylsemiquinonate (3,5-DBSQ). A 
further one-electron oxidation would produce the neutral species 3, 5-di-tert-butyl-ortho-
benzoquinone, as shown in Figure 2146. 
 
Figure 21: Redox active states of a substituted catecholate ligand46  
X-ray crystallographic data showed that Co(3, 5-DBCat)(3, 5-DBSQ)(bpy) was a 
Co(III)complex in the crystalline state, with one dianionic catecholate and one monoanionic 
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semiquinone ligand46. Electron paramagnetic resonance (EPR) and NMR spectroscopy showed 
an equilibrium between Co(3,5-DBCat)(3,5-DBSQ)(bpy) and its electroisomer, the Co(II) 
complex  Co(3,5-DBSQ)2(bpy).This conclusion is based on mostly bond lengths in the ligands
46. 
Electroisomerism is a phenomenon in which a low-lying electronic excited state is thermally 
accessible. This is different from most electronic excited states, which are sufficiently higher in 
energy than the ground state that they require the absorption of light to be promoted, as occurs in 
UV-visible spectroscopy46.   This electroisomerization equilibrium is shown in Figure 2246.   
  
Figure 22: Electroisomerization equilibrium in a cobalt catecholate complex46 
Another example of a redox- active ligand is-  
2,4-di-tert-butyl-6-tert-butylamidophenolate, studied by the Heyduk group47.  The metal in this 
example is Zr(IV) with a d0 electron count. An important difference between Pierpont’s work 
and Heyduk’s work is that in Pierpont’s work the oxidation state of the metal (Co) changes along 
with changes in the ligand properties. However in Heyduk’s work 47, the   oxidation of the metal 
does not change, but the electron density of the ligand changes. Heyduk’s complex shows ligand- 
based redox activity in response 
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to treatment with an oxidizing agent48. While, Peirpont’s complex exhibits a thermal equilibrium 
with no additional reactant46.  
This reaction can be considered analogous to oxidative addition and reductive 
elimination. In classical oxidative addition reactions, the oxidation state of a metal center 
increases by two48. Reductive elimination is the reverse of oxidative elimination. Figure 23 
shows a reaction similar to oxidative addition with Cl2 or PhICl2.and a reaction similar to 
reductive elimination where there is a release of biaryl product from a Zr diaryl 
complex.  In both the cases the ligands serve as electron sources (electron density comes from 
them) 48.  
 
Figure 23: Ligand-based pseudo-oxidative addition and reductive elimination reactions of Zr 
(IV) complexes47 
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CHAPTER III 
MATERIALS AND METHODS 
3.1 Single crystal x-ray diffraction 
The block diagram of an x-ray diffractometer is shown in Figure 2448.  
 
 Figure 24: Block diagram of x-ray diffractometer48 
The x-ray tube is a vacuum tube which converts electrical input power into x-rays48. A 
collimated x-ray beam is incident on a crystal and is scattered into an ionization chamber48. The 
crystal and ionization chamber are rotated in order to keep both the angles of incidence and 
scattering equal. The ionization in the chamber is measured as a function of angle, the spectrum 
of the x-rays is determined by Bragg’s law-(n= 2d sin where is the wavelength of the 
incident wave, n is a positive integer, d is the lattice spacing, is when the constructive 
interference is the maximum48.  
Important terms used in X-ray crystallography 
1. Thermal ellipsoids: They show the magnitude and directions of thermal vibrations of atoms 
in crystal structures.  
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They are also known as atomic displacement parameters49.  
The popular ORTEP pictorial representation of crystal structures stands for Oak Ridge Thermal 
ellipsoid plot (Oak Ridge, Tennessee is the site of a major national laboratory)49.   
2. Crystal system: Crystals are divided into 7 fundamental lattice systems. The crystal systems 
are- monoclinic, tetragonal, triclinic, trigonal, hexagonal, orthorhombic, and cubic49.  
3. R factor: It is also known as the agreement parameter. It is a measure of agreement between 
the crystallographic model and the actual X-ray diffraction data49.  
3.2 UV-visible spectroscopy (UV-Vis) 
A block diagram of a UV- Vis spectrometer is shown in Figure 2551.  
 
Figure 25: Block diagram of UV-Vis spectrometer51     
 a. Source: Hydrogen, deuterium, and xenon arc lamps are the most frequently used sources in 
UV-vis spectrometers51.  
b. Wavelength selector: Several monochromators and filters are classified as single wavelength 
selectors51.  
c. Reference: It is also known as the blank, and is the solvent which has been used to dissolve the 
sample. It is exposed to the same radiation as the sample51. 
d. Detector: Photomultiplier tubes are detectors used in UV-vis spectrometers. These give off 
electrons in response to radiation51.  
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Beer- Lambert’s law/equation  
The Beer-Lambert’s law states that A = εbc, where A= absorbance, ε = molar absorptivity, b = 
path length, and c = concentration52. The standard units of b and c are cm and M, respectively, so 
 values are usually given in units of M-1·cm-1, since A is a unitless quantity.  
3.3 Fourier Transform-Infrared spectroscopy (FT-IR, solid phase, ATR) 
The block diagram of IR spectrometer is shown in Figure 2653. 
 
 
 Figure 26: Block diagram of IR spectrometer53 
The source produces radiation, which moves the sample via interferometer and reaches the 
detector53. The interferometer consists of a beam splitter, a fixed mirror, and a mirror y. The beam 
splitter is made of a special material that transmits half of the radiation striking it and reflects the 
other half. Radiation from the source strikes the beam splitter and separates into two beams53. One 
beam is transmitted through the beam splitter to the fixed mirror and the second is reflected off the 
beam splitter to the moving mirror. The fixed and moving mirrors reflect the radiation back to the 
beam splitter. Again, half of this reflected radiation is transmitted and half is reflected at the beam 
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splitter, resulting in one beam passing to the detector and the second back to the source53. IR 
spectroscopy is a type of vibrational spectroscopy. IR active molecules show a change in dipole 
moment.  
3.4 EPR Spectroscopy (EPR) 
The block diagram of EPR spectrometer is shown in Figure 2754, 
     
  
Figure 27: Block diagram of EPR spectrometer 
A klystron is the radiation source used. The radiation could be continuous wave or pulsed 
The sample is located in a resonant cavity54. The cavity is placed in the middle of an 
electromagnet, and intensifies weak signals from the sample. The source and detector have a 
microwave bridge control. Modulation input is used to enhance the performance of the 
instrument54. Phase sensitive detection used to obtain spectra with good sensitivity. EPR is an 
accomplished, nondestructive, and analytical technique. It has various applications in radicals, 
oxidation, reduction, and reaction kinetics54. The frequency of the radiation is held constant, 
whereas the magnetic field is varied. If the electron is placed in an applied magnetic field B0 , the 
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two spin states have contrasting energies. The lower energy is when the electron’s magnetic 
moment µ is aligned with the magnetic field55. 
The higher energy state is when µ is aligned in the opposite direction of the magnetic field55. 
Denoting the electron’s spin quantum number (the projection of its spin angular momentum, in 
units of ħ, along the z-axis) by ms, when ms = +1/2 it is the antiparallel state, and when ms = -1/2, 
it is the parallel state. 
The energy states of the electron are given by the following formula67- 
E = gµBB0ms 
Where g is the Landé factor 
µB is the Bohr magneton 
B0 is the applied magnetic field 
ms is the spin quantum number 
3.5 Elemental Analysis (EA) 
     Procedure:  During the combustion process, carbon atoms in the sample are converted to 
carbon dioxide, hydrogen atoms to water, and nitrogen to elemental nitrogen gas/nitrogen oxides56. 
The combustion products are cleaned out of the combustion chamber by the use of an inert gas 
like helium and moved over high-purity copper.  The copper removes the oxygen that was not used 
in the initial combustion, and to convert oxides of nitrogen to nitrogen gas 56. The two carrier gases 
used are thus helium and oxygen. The detection of gases is done by a GC column56.  
3.6 Magnetic Susceptibility measurements 
Magnetic susceptibility is a measure of capacity of a material to be magnetized when placed 
in a magnetic field57.  The following formulas are used to determine the magnetic susceptibility- 
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cgs units are used for magnetic susceptibility calculations. For magnetic susceptibility per gm in 
cgs units, the following formula is used- 
𝜒𝑔 =
𝐿
𝑚
(𝑅 − 𝑅0)/10
9 
Where χg=magnetic susceptibility per gram 
L = height of the sample tube in cm 
m = mass of the sample in grams 
R = magnetic susceptibility reading of the tube and sample together 
 R0 = magnetic susceptibility of the empty tube 
To obtain the magnetic susceptibility per mole χmol, the formula below is used- 
𝜒𝑚𝑜𝑙 = 𝑀𝜒𝑔  
Where M = molar mass of the compound (in units of g/mol) 
The χdia is the magnetic moment due to diamagnetic effects which is due to the core electrons of 
all atoms in the molecule which includes the paired core electrons of the transition metal and paired 
electrons in covalent bonds57. 
𝜒corr = 𝜒𝑔 − 𝜒dia 
Where χcorr = corrected magnetic susceptibility per mole 
The effective magnetic moment µeff is calculated by the following formula- 
µeff = 2.828√𝜒corr𝑇 
 
The spin only magnetic moment µs in units of the Bohr magneton µB , whose value in SI units is 
9.274 x 10-21 JT-1.  is given by the following formula- 
µ𝑠 = √𝑛 (𝑛 + 2) 
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Magnetic susceptibility measurements were carried out at 22 oC, and an effective 
magnetic moment of 3.81 B was calculated using the list of diamagnetic corrections compiled 
by Bain and Berry58.  
Cyclic Voltammetry (CV) 
CV is a very useful electrochemical technique for the study of reduction and oxidation 
process of molecular species .The block diagram of an electrochemical cell suitable for CV 
experiments is shown in Figure 2859.  
 
 
Figure 28: Block diagram of CV59 
1. Supporting electrolyte; A good supporting electrolyte has the following features59-: 
a. Highly soluble in solvent  
b. Able to be thoroughly purified 
c. Chemically and electrochemically inert to the system under study 
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To increase solution conductivity, high electrolyte concentrations are needed. The presence of 
supporting electrolyte is especially important because the supporting electrolyte increases the 
conductivity of the non-aqueous solvent. The supporting electrolyte will shift to balance the charge 
and complete the circuit when electron transfer occurs at the electrodes59.  
2. Working electrode: The use of the working electrode is to perform the electrochemical reaction 
by applying a potential. It is made of material that is redox-inert in the potential range of interest59.  
It is pivotal that the electrode surface of the working electrode be thoroughly clean because the 
electrochemical reaction of interest occurs at that surface59 
3. Reference electrode:  A reference electrode has a stable equilibrium potential. It is considered 
as a reference point in contrast to the other potential of other electrodes that are measured in an 
electrochemical cell59.  
4. Counter electrode: Current begins to flow when a potential is applied to the working electrode 
and reduction or oxidation of the analyte can occur59. When the electrons flow between the counter 
and working electrode, the current is recorded. The surface area of the counter electrode is higher 
compared to the surface area of the working electrode59.  
5. Degassing hole: Degassing is performed to remove oxygen. Oxygen needs to be removed to 
avoid redox processes for oxygen59.  
Important terms used in CV 
1. Voltammogram: It is defined as a plot of cell current vs the potential obtained from a 
voltammetry experiment59.  
2. Ohmic drop: Electrolytic solutions have an intrinsic solution Rsol. There is a part of 
uncompensated resistance (Ru) between the working electrode and reference electrode
59. The 
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potential that is recorded by the instrument may not be the potential experienced by the analyte in 
solution. This is due to the uncompensated resistance59.  
3. Overpotential: Overpotential is the potential difference between a reduction potential 
determined thermodynamically and the potential at which redox event is experimentally 
observed60.  
3.8 Gas Chromatography/Mass Spectrometry (GC-MS) 
In GC-MS two techniques (gas chromatography and mass spectrometry) are merged to 
produce a single method for analyzing mixtures of chemicals61.A block diagram for GC-MS is 
shown in Figure 2961.  
 
Figure 29: Block diagram of GC-MS61 
The carrier gas is the mobile phase. Examples of carrier gas include helium, and 
nitrogen61. Micro syringe, split/split less are different injection methods. There are 2 types of 
columns, packed and capillary 61.  The optimum column temperature varies on the boiling point 
of the solvent. When the separate compounds elute from the GC column, they enter the mass 
spectrometer detector 61. These fragments have mass and are charged, being separated by the 
mass over charge (m/z) ratio. The computer produces a graph for each scan 61. The m/z ratio is 
shown on the x-axis and the signal abundance is shown on the y-axis.  
Nuclear Magnetic Resonance Spectroscopy (NMR) 
The block diagram of a NMR spectrometer is shown in Figure 3062. 
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Figure 30: Block diagram of NMR62  
NMR spectrometers have the ability to apply RF pulses to a sample placed in a high 
magnetic field. They can detect the time response of the spins subsequent to the pulse 62.  The 
magnet and the probe are very important parts of the NMR spectrometer. The probe is a tuned 
resonant circuit 62.  
Important terms used in NMR spectroscopy 
1. Chemical shift: The chemical shift can be defined as the position on the δ scale where the 
peak appears. The unit of chemical shift is ppm 81. The formula to obtain chemical shift is62- 
 𝛿 = 𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 𝑜𝑓 𝑠𝑖𝑔𝑛𝑎𝑙 − 𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 𝑜𝑓 𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 ×
106
𝑠𝑝𝑒𝑐𝑡𝑟𝑜𝑚𝑒𝑡𝑒𝑟
 
2. Chemically equivalent protons: They are in the same magnetic environment 62. They also 
undergo the same magnetic force and produce overlapping signals on the spectrum.  
3. Integration: Integration gives information on the relative number of protons that produces a 
signal 62.  
4. Multiplicity: It is defined as the number of peaks in a signal 62.  
5. N+1 rule: N refers to the chemically equivalent protons which are bonded to adjacent carbons  
6. Coupling constant (J): It is the distance62 between two neighboring peaks in a signal.   
7. Shielding and deshielding: The phenomenon of shielding leads to a nucleus experiencing a 
weaker net magnetic field.  
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Shielding means that the frequency is upfield and the signal is observed at a lower chemical 
shift62. In deshielding the nucleus experiences a stronger net magnetic field and the frequency is 
downfield and the signal is observed at a higher chemical shift62.   
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CHAPTER IV 
SYNTHESIS & CHARACTERIZATION OF COBALT (II) N,N´-AZODIOXIDE 
COMPLEXES  
4.1 Reaction scheme and procedure: The reaction conditions used were different from those 
used by Nicholas et al. were changed38.The proposed reaction scheme, depicting the reaction 
initially hypothesized, is shown in Figure 3163 
 
Figure 31: Attempted synthesis of azodioxide products with different metal salts using thallium-
based chloride abstraction 63 
We used a thallium salt (TlPF6) for chloride abstraction for the following reasons:  
1. We hypothesized that this would help us obtain products in which the transition metal was 
present in only one oxidation state (unlike Nicholas’s reaction where a combination of + 2 and 
+3 oxidation states were observed for Fe). 
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2. To get a diamagnetic anion, PF6
-, because the presence of the strongly paramagnetic FeCl4
- 
anion in Nicholas’s product can interfere with spectroscopic and magnetic measurements.  
3. To avoid strong cation-anion interactions by using a non-coordinating anion.  
4. We do not use Ag+ because it is a fairly strong oxidizing agent whereas Tl+ is not a strong 
oxidizing agent even though AgCl is similarly insoluble. 
 Out of all the metal chloride reactions with TlPF6 and PhNO, cobalt was the metal which 
produced successful results. The reaction of the cobalt salt (CoCl2) and TlPF6 and PhNO is 
shown in Figure 3264. The synthesis of this complex has been published in ACS Omega64 
 
Figure 32: Synthesis of [Co{Ph(O)NN(O)Ph}4](PF6)
64 
Procedure: In the glovebox, 0.206 g (1.58 mmol) anhydrous CoCl2 was suspended in 30 
mL acetonitrile and stirred64. To this stirred suspension was added a solution of 1.11 g (3.17 
mmol) TlPF6 in 5 mL acetonitrile
64. A white precipitate of TlCl was immediately observed, 
along with the appearance of a light pink color in solution. After 15 minutes, a solution of 1.30 g 
(12.1 mmol) PhNO in 20 mL acetonitrile was added, and the solution was stirred for 2 days at 
room temperature64. The reaction mixture was then filtered through a fritted-glass funnel to 
remove TlCl, and solvent was removed from the filtrate under vacuum to yield the crude 
product64. The crude product was dissolved in a minimal amount of dichloromethane and placed 
in the glovebox freezer at -30 °C overnight, after which some unreacted PhNO dimer 
crystallized64. The supernatant was removed from the PhNO dimer crystals and transferred into 
another vessel. Hexane was gently layered on top of the supernatant, and the mixture returned to 
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the freezer for an additional 2.5 days, yielding black crystals of [Co{Ph(O)NN(O)Ph}4](PF6)2 
suitable for X-ray diffraction64. The crystals were removed with a spatula from a powdery co-
precipitate, and put under vacuum, yielding 0.50 g [Co{Ph(O)NN(O)Ph}4](P F6)2 (0.41 mmol, 
26%)64.  
Single crystal x-ray diffraction 
Rationale for using single crystal x-ray diffraction for this project 
Single crystal x-ray diffraction was used to identify bond lengths, bond angles, of cobalt complexes 
Procedure: X-ray crystallography was performed in collaboration with Dr. Wiley Youngs 
and Mr. Michael. Stromeyer.  Crystal of [Co{Ph(O)NN(O)Ph}4](PF6)2was coated in paratone 
oil, mounted on a CryoLoop, and placed on a goniometer under a stream of nitrogen. Crystal 
structure data sets were collected on a Bruker Kappa APEX II Duo CCD system equipped with 
an Mo ImuS source and a Cu ImuS micro-focus source equipped with QUAZAR optics (= 
1.54178 Å). The unit cells were determined by using reflections from three different orientations. 
Data sets were collected using APEX II software packages. All data sets were processed using 
the APEX II software suite. The data sets were integrated using SAINT5An empirical absorption 
correction and other corrections were applied to the data using multi-scan SADABS50. 
Structure solution, refinement, and modelling were accomplished by using the Bruker SHELXTL 
package. The structure was determined by full-matrix least-squares refinement of F2 and the 
selection of the appropriate atoms from the generated difference map. Hydrogen atoms were 
calculated and Uiso(H) values were fixed according to a riding model 
X-ray structure of [Co{Ph(O)NN(O)Ph}4](PF6)2 
The x-ray structure of [Co{Ph(O)NN(O)Ph}4](PF6)2 is shown in Figure 33. 
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Figure 33: Thermal ellipsoid plot of [Co{Ph(O)NN(O)Ph}4](PF6)2, with thermal ellipsoids drawn 
to 50% probability and hydrogen atoms and one PF6
- anion omitted for clarity49 
The coordination geometry of the cobalt complex [Co{Ph(O)NN(O)Ph}4](PF6)2] is 
tetragonal and the coordination number is 8. The mean N-N and N-O bond lengths are 1.31 and 
1.28 Å, respectively49. The mean Co- O bond length is 2.24 Å49. The Co–O bond lengths in 
[Co{Ph(O)NN(O)Ph}4]
2+ 38, are significantly longer than the Fe–O bond lengths in 
[Fe{Ph(O)NN(O)Ph}3]
2+, but considerably shorter than the Ca–O (azodioxide) bond lengths in 
[Ca{Ph(O)NN(O)Ph}(H2O)2(THF)3]
2+  42.    The chelate rings in [Co{Ph(O)NN(O)Ph}4]
2+ are 
not planar, instead assuming a puckered “envelope” conformation with the Co atom lying outside 
of the plane of the N and O atoms, in contrast to the Fe and Ca complexes, which both contain 
planar chelate rings49.  
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The similarity in metrical parameters for free Ph(O)NN(O)Ph and Ph(O)NN(O)Ph coordinated to 
Fe or Co suggests that the electronic environment of this species does not vary drastically upon 
coordination. The significant difference in metal–ligand bond lengths between 
[Fe{Ph(O)NN(O)Ph}3]
2+ and [Co{Ph(O)NN(O)Ph}4]
2+ is thus proposed to be primarily due to 
steric, as opposed to electronic, reasons: the Co–O bonds are elongated to accommodate a larger 
number of ligands around the Co(II) center49. The still greater Ca–O bond length in seven-
coordinate [Ca{Ph(O)NN(O)Ph}(H2O)2(THF)3]
2+ may reflect a greater ion-dipole component to 
the bonding of Ph(O)NN(O)Ph to an alkaline earth metal, compared to the greater covalent 
character of its bonding to transition metals with valence d orbitals42 . The bond length and bond 
angle parameters are shown in Table VI64 on page 48. 
 Crystal data for [Co{Ph(O)NN(O)Ph}4](PF6)2: C48H40CoF12N8O8P2, M = 1205.75, 
tetragonal, a = 12.8106(4) Å, b = 12.8106(4) Å, c = 30.5131(10) Å, 
 = 90º, = 90º,  = 90º, V = 5007.5(12) Å3, T = 100(2) K, space group I41/a, Z = 4,  22041 
reflections measured, 2536 independent reflections (Rint = 0.0308)
49. The final R1 values were 
0.0295 (I > 2 (I)). The final wR(F2) values were 0.0647 (I > 2 (I)).  
The final R1 values were 0.0370 (all data). The final wR(F2) values were 0.0688 (all data)49. 
A coordination number of 8 is very unusual for Co (II). The only monometallic, eight-
coordinate Co (II) complexes thus far characterized are dodecahedral (Ph4As)2[Co(NO3)4], 
prepared by Bergman and Cotton58, dodecahedral [CoL2](ClO4)2, where L = 2,11-
diaza[3.3](2,6)pyridinophane, prepared by Krüger and coworkers59, and the crown ether complex 
cations [Co(12-crown-4)2]
2+ and [Co(benzo-12-crown-4)2]
2+, prepared as salts of various 
polyiodide anions by Meyer and coworkers,60 both of which display square antiprismatic 
coordination. Examples of transition metal complexes other than that of cobalt which are eight 
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coordinate are the following: [Fe(1,8-napthyridine)] Cl2 prepared by Hendricker and Bodner
61 
displays a distorted dodecahedral geometry. The other examples are- [Mn(DOTAM)]2+ , and 
[Ca(DOTAM)]2+,  where DOTAM = 1,4,7,10-tetrakis(acetamido)-1,4,7,10-
tetraazacyclododecane, prepared by Westmoreland and co-workers62  
UV-visible spectroscopy (UV-Vis) 
 Rationale for using UV-vis spectroscopy for this project  
UV- visible spectroscopy has importance in transition metal complexes because colored 
complexes display peaks in the UV regions. UV-Vis spectroscopy was also performed to 
compare the wavelengths and molar absorptivities of the product and reactants52. This is a 
common technique which synthetic chemists use to illustrate differences between products and 
reactants.  
Procedure 
A certain mass of the [Co{Ph(O)NN(O)Ph}4](PF6)2 sample was weighed and was 
dissolved in acetonitrile in  a 10 ml volumetric flask (stock solution) in the glove box This stock 
solution was further diluted to different concentrations (working solutions) in the glove box. A 
calibration curve was plotted between the absorbance (y axis) and the concentration (x axis). The 
molar absorptivity was calculated using the Beer- Lambert’s law shown. 
Results and Discussion: The UV- Vis spectrum of [Co{Ph(O)NN(O)Ph}4](PF6)2 is shown in 
Figure 34.  
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Figure 34: UV-vis spectrum of [Co{Ph(O)NN(O)Ph}4](PF6)2 
The peak wavelength of the cobalt complex and molar absorptivity is shown in Table I64. 
Peak wavelength of the cobalt complex 
(max, nm) 
Molar absorptivity (, M-1·cm-1) 
282 5.36 × 104 
305 4.62 × 104 
Table I: Peak wavelength and molar absorptivity of ([Co{Ph(O)NN(O)Ph}4](PF6)2 
64  
In figure 34, there is a wavelength marked as A. It is not the max this is because this 
wavelength is not the same for all the concentrations.  
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The UV- Vis spectrum of the nitrosobenzene in the monomeric form (azodioxide ligand) is 
shown in Figure 35.  
 
Figure 35: UV-Vis spectrum of nitrosobenzene (monomeric) form of the ligand  
The peak wavelength of nitrosobenzene and molar absorptivity is shown in Table II64. 
Peak wavelength of nitrosobenzene (max, 
nm) 
Molar absorptivity (, M-1·cm-1) 
218 1.25 × 105 
237 8.70 × 103 
282  1.69 ×105 
Table II: Peak wavelength and molar absorptivity of nitrosobenzene64 
An additional peak with max = 282 nm ( = 5.36 × 104 M-1·cm-1) may be due to residual 
PhNO as an impurity, as the UV-visible spectrum of pure PhNO in acetonitrile displays a strong 
peak at this wavelength64. Residual PhNO may also give rise to the peak at 282 nm in the UV-
visible spectrum of [Fe{Ph(O)NN(O)Ph}3](FeCl4)2 as measured by Nicholas’ group38. The Beer-
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Lambert law plots for absorbance vs. concentration at each peak wavelength were linear, 
suggesting that the azodioxide (Ph(O)NN(O)Ph) ligands do not dissociate in solution to a 
significant extent, as such dissociation would be expected to be concentration-dependent. 
FT-IR spectroscopy (solid phase, ATR) 
Rationale for using FT-IR spectroscopy (solid phase, ATR) in this project 
FT-IR spectroscopy was used to compare the N-O stretching frequencies between the 
reactant and the product. Also, oxygen can easily diffuse in the solution state,(this complex is 
fairly oxygen and moisture sensitive) so solid-phase IR spectroscopy was chosen.  
The IR- spectrum of the cobalt azodioxide complex is shown in Figure 36 64.   
 
Figure 36: Infrared spectrum of [Co{Ph(O)NN(O)Ph}4](PF6)2 (solid phase)
64 
Table III shows the frequency and the corresponding peaks in the IR spectrum of the cobalt 
azodioxide complex64. 
Frequency (, cm-1)  Peaks 
666 strong 
690 strong 
765 strong 
1167 strong 
1370 broad 
1460 broad 
1484 broad 
Table III: IR parameters of the cobalt azodioxide complex64 
The IR spectrum of cis-Ph(O)NN(O)Ph (solid phase) is shown in Figure 3764. 
 
39 
 
 
Figure 37: IR spectrum of cis-Ph(O)NN(O)Ph (solid phase)64 
 
Table 1V shows the frequency and corresponding peaks in the IR spectrum of  
cis-Ph(O)NN(O)Ph64 
 
Frequency (, cm-1) 
 
Peaks 
665 strong 
689 strong 
761 strong 
1191 strong 
1390 strong, broad 
1458 strong, broad 
1485 strong, broad 
Table 1V: Frequency and corresponding peaks in the IR spectrum of cis-Ph(O)NN(O)Ph64 
 
The peaks that are important are the peaks marked in purple in Table III and the peaks 
marked in orange in table 1V. This is because these are the peaks that correspond to the N-O 
stretching frequencies.   The cobalt complex shows a somewhat less strong band at 1370 cm-1 
and weaker bands at 1460 and 1484 cm-1 compared to free azodioxide36.The similarity of the N-
O stretching frequencies between free and bound Ph(O)NN(O)Ph is consistent with a fairly small 
effect of coordination on the electronics of the ligand. It is also important to mention that 
Nicholas and co-workers observed bands at 1374, 1462, and 1481 cm-1 in the IR spectrum of 
[Fe{Ph(O)NN(O)Ph}3](FeCl
4)2.
38 . This provides additional evidence for a small effect of 
coordination on the electronics of the ligand.  
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Electron Paramagnetic Resonance spectroscopy (EPR) 
Rationale for using EPR spectroscopy in this project 
 EPR was used because the cobalt azodioxide complex is a paramagnetic complex. A paramagnetic 
substance has one or more unpaired electrons.  
Procedure: EPR measurements were carried out in collaboration with Dr. David Tierney’s 
research group and the EPR technician Dr. Robert McCarrick at Miami University.  
Measurements were done at 4.5 K. This low temperature was chosen because the cobalt azodioxide 
complex has multiple unpaired electrons.  
The solvents used were acetonitrile and dichloromethane (good “glass” for low temp EPR). The 
sample was prepared in a glove bag. Glass here means like the glass (amorphous solid).  
The EPR spectrum of [Co{Ph(O)NN(O)Ph}4](PF6)2 is shown in Figure 38.  
 
Figure 38: EPR spectrum of the cobalt homoleptic complex 
 
The EPR spectrum is a plot of magnetic field strength v/s signal intensity. The cobalt complex 
is shown as a single peak.  
The g-factor was calculated using the following formula- hν = gμBB 
h= Planck's constant 
ν = 9.634 GHz (frequency of the EPR instrument) 
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B = 1670 G (0.167 T) (Magnetic field strength) (average of both the values of magnetic 
field strength from Figure 35) 
μB=9.274 × 10-24J/T (Bohr magneton) 
g=4.12 
The g value for organic radicals is close to 2 65a. The g value for the cobalt complex of 4.12 
is a good indication of radical character not mainly centered on organic ligands, thus suggesting a 
primarily Co-centered radical65b. 
Elemental analysis  
Rationale for elemental analysis in this project 
Elemental analysis was done to determine the purity of the cobalt azodioxide sample. These 
measurements were carried out at Galbraith Labs. The results of elemental analysis of the cobalt 
azodioxide sample are summarized in Table V64  
Parameters Observed Predicted 
%C 34.26 47.81 
%H 2.79 3.34 
%N 8.68 9.29 
Table V: Elemental analysis parameters of the cobalt azodioxide sample64  
The results indicate that there is some impurity. The impurity may be a thallium (I) salt, 
since TlPF6 was used in the synthesis and (mostly insoluble) TlCl was generated as a byproduct. 
A fairly small amount of a Tl compound in terms of mole percent can lead to a significant deviation 
from predicted mass percentages, due to the high molar mass of Tl (204.38 g/mol)64. There is 
unlikely to be any paramagnetic, Co-containing impurity, as the EPR spectrum is indicative of 
only one paramagnetic species64. 
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Magnetic susceptibility measurements 
Rationale for magnetic susceptibility measurements 
Magnetic susceptibility measurement are useful in paramagnetic complexes as they determine the 
number of unpaired electrons.  
Results and Discussion: Magnetic susceptibility measurements were carried out at 22 oC, and an 
effective magnetic moment of 3.81 B was calculated using the list of diamagnetic corrections 
compiled by Bain and Berry71. This value is close to the spin-only value of 3.87B for a Co (II) 
species with 3 unpaired electrons72.  The diamagnetic impurity mentioned above is responsible for 
the magnetic moment being lower than the spin only theoretical value. Normally, the observed 
 magnetic moments are higher than the spin-only value because the orbital angular momentum 
contribution is only partially quenched64.  
4.2 Synthesis of [Co(bpy){Ph(O)NN(O)Ph}2](PF6)2 
This complex was prepared by my coworker Ms. Kylin Emhoff, another Ph.D. student in the 
Boyd group.  The tetrahedral Co(II) complex Co(bpy)Cl2, whose preparation was reported by 
Iqbal and coworkers,72 as a synthon for a heteroleptic bpy/azodioxide complex. Treatment of this 
blue complex with 2 equiv. TlPF6 in acetonitrile to remove   Cl
- as insoluble TlCl, followed by 
addition of excess PhNO, yields the six-coordinate complex cation salt  
 [Co(bpy){Ph(O)NN(O)P h}2](PF6)2 The reaction scheme is shown in Figure 39
64.  
 
Figure 39:  Synthesis of [Co(bpy){Ph(O)NN(O)Ph}2](PF6)2
 64 
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Filtration of the reaction mixture of Figure 42, followed by removal of acetonitrile solvent 
in vacuo and recrystallization from dichloromethane/diethyl ether yielded garnet-red crystals of 
[Co(bpy){Ph(O)NN(O)Ph}2](PF6)2 suitable for analysis by single-crystal X-ray diffraction. The 
crystal structure is shown in Figure 4064.  
 
Figure 40: Thermal ellipsoid plot of [Co(bpy){Ph(O)NN(O)Ph}2](PF6)2 
It is proposed that the reaction proceeds by initial replacement of Cl- by solvent to 
form[Co(bpy)(NCMe)n]2+, where n = 2 or 4, based on the immediate appearance of a peach color 
upon addition of TlPF6 to the blue Co(bpy)Cl2. This is notably different from the light pink color 
observed upon addition of TlPF6 to a solution of the simple salt CoCl2 in acetonitrile, suggesting 
that bpy remains coordinated to the Co (II) center prior to the addition of PhNO49.The 
[Co(bpy){Ph(O)NN(O)Ph}2]2+ cation has a trigonal prismatic geometry, similar to 
[Fe{Ph(O)NN(O)Ph}3]2+, with idealized C2v symmetry assuming free N–phenyl bond rotation 
. 
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    Table VI shows that the N–N and N–O bond lengths in [Co(bpy){Ph(O)NN(O)Ph}2]2+ are 
similar to those in free Ph(O)NN(O)Ph and other diarylazodioxide complexes49. 
 Interestingly, the Co–O bond lengths in this complex are very close to the Fe–O bond lengths in 
[Fe{Ph(O)NN(O)Ph}3]2+, despite the differing d electron counts of the transition metals in these 
complexes: d6 for Fe(II) and d7 for Co(II)38. However, the average metal–azodioxide oxygen bond 
length does increase significantly from these six-coordinate complexes to the seven-coordinate, d0 
complex [Sc{Ar(O)NN(O)Ar}(H2O)2(OSO2CF3)]41 and the eight-coordinate, d7 complex 
[Co{Ph(O)NN(O)Ph}4]2+. The number of crystallographically characterized azodioxide 
complexes remains small, thus making it difficult to determine a general trend, but from the limited 
number of structures known, coordination number, rather than metal or d electron count, seems to 
be the primary determinant of metal–ligand bond distance in azodioxide complexes, with the 
seven-coordinate, alkaline earth complex [Ca{Ph(O)NN(O)Ph}(H2O)2(THF)3]2+ an exception, as 
mentioned previously42. The average bond lengths and bond angles of the azodioxide complexes 
are shown in Table VI64. 
Compound 
 
 
 
Mean 
N–N 
bond 
length 
(Å) 
 
 
Mean 
N–O 
bond 
length 
(Å) 
 
 
Mean 
M–O 
bond 
length 
(Å) 
 
 
Reference 
 
 
Free azodioxide 1.32 1.27 N/A 36 
[Fe(azodioxide)3](FeCl4)2 1.29 1.28 2.12 38 
[Co(azodioxide)4](PF6)2 1.31 1.28 2.24  64 
[Co(bpy)(azodioxide)2](PF6)2 1.31 1.28 2.10 64 
[Sc(azodioxide)(H2O)2(OTf)3] 1.29 1.28 2.21 41 
[Ca(azodioxide)(H2O)2(THF)3]I2 1.30 1.27 2.42 42 
Table VI: Mean bond length and mean bond angles of azodioxide complexes64 
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Chapter V 
REDOX ACTIVITY MEASUREMENTS OF [Co{Ph(O)NN(O)Ph}4](PF6)2 
5.1 Rationale 
Redox activity is a property of chemical system. Different physical measurements 
(spectroscopic, electrochemical, and magnetic) are used to probe redox- activity. Redox- activity 
is useful in determining metal-based vs ligand-based redox activity. This study is interesting 
because azodioxides have the potential to behave as redox-active ligands due to the delocalization 
of their systems. This concept has been further explained in chapters I and II.  
5.2 Cyclic Voltammetry (CV) 
Background on CV of cobalt complexes 
Kumar and coworkers studied cobalt and ruthenium complexes with N2S2, N4, and N5 
donor macrocyclic ligands by spectroscopic and cyclic-voltammetric methods73.  The cobalt 
complexes synthesized were Co(L1)(NCS)2 and Co(L2)(NCS)2 .where L1 and L2  are- L1—1,4-
diphenyl-1,5-diaza-8,11-dithiacyclotrideca-1,4-diene 
and ligand L2—2,4,9,11-tetraphelyl-6,13-dimethyl-1,5,8,12-tetraazacyclotetradeca-1,4,8,11-
tetetraene, CV was used to explain whether the Co or the ligands undergo redox reactions more 
easily.  The redox behavior of the cobalt complexes were detected using dimethyl sulfoxide 
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(DMSO) as the solvent and a glassy carbon electrode. A single, strong peak, which was not 
shown by the free ligands, corresponds to oxidation of Co(II) to Co(III)73.  The complexes show 
quasi-reversible oxidation processes shown by the peak-to-peak separation (Ep > 100 mV) and 
show redox potentials in the range of 1.0–1.25 V. In all cobalt (II) complexes the cathodic and 
anodic peak heights (ipc and ipa) were found to be the same. For the reduction process of the 
cobalt complexes73, Ep values were found to be greater than 60 mV. The ratio between the 
cathodic peak current and square root of scan rate is roughly constant. For the oxidation process, 
the CV of cobalt (II) displays two peaks, corresponding to two single-electron processes.The 
functional groups in the ligands act as potential electron transfers.   The difference between the 
anodic peak and cathodic peak potential is constant. 
Another paper by Kevan and coworkers74 showed a cobalt (II) complex covalently bound 
to MCM-41 support. MCM-41 is a member of family of mesoporous molecular sieves with 
siloxy groups74. Ethylenediamine (ED), diethylenetriamine (DET), and ethylenediaminetriacetic 
acid salt (EDT) functionalized sites are produced from silanation of MCM-4174 Silanization of 
MCM-41 was done to functionalize it . CV of the cobalt complex functionalized MCM-41 was 
performed using a three-electrode cell.The solvents used were acetonitrile and DMSO, with 
etrabutylammonium tetrafluoroborate as the supporting electrolyte. Composite electrodes consist 
of a mixture of graphite and sample pressed against a platinum gauze74. The CV of Co-M41ED, 
Co-M41DET, and Co-SilED samples showed a well-defined anodic peak followed by a 
considerably smaller cathodic signal, centered at +1.1 V vs. SCE (standard calomel electrode)74. 
The anodic and cathodic peak intensities decayed with consecutive oxidation cycles. When the 
electrode was aged in solution(analyte is a part of the electrode and not in solution) for 30 min, 
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before the collection of the first cycle, the following by oxidation cycles show a similar decay74. 
This is due to the fact that the decay is due to an irreversible reaction.  
Decay here refers to not a reaction coupled to electrochemical processes, if it occurs in solvent 
before any CV is performed. 
Another paper by Elliot and coworkers showed CV studies on cobalt poly-
4‑t‑butylpyridine ligand complexes75.  The two complexes used were the pseudo-octahedral 
complexes of 4,4′-di-t-butyl-2,2′-bipyridyl, [Co(DTB)3]2+/3+, and  
4,4′,4″- tri-t-butyl-2,2′:6,2″-terpyridine, [Co(TTT)2]2+/3+.The working electrode used was glassy 
carbon electrode. The solvent used was acetonitrile75. The ΔEp values for the Co (II/III) in every 
case are less than 100 mV, showing a nearly Nernstian behavior and minimal ohmic drop even at 
scan rate of 500 mV/s 75.  
Another paper by Anson and coworkers showed CV studies on 2,2´-bipyridyl complexes 
of cobalt in the presence of acrylonitrile76. The reference electrode used in this case was a silver 
wire immersed in 0.1 M AgNO3 in acetonitrile. This was double isolated from the main cell 
compartment by fritted glass double funnels75. The potential of this electrode was 392 mV more 
positive compared to an aqueous SCE when both were immersed in 0.01M aqueous KNO3. The 
working electrode used was a cylindrical platinum gauze electrode with a heavy platinum wire75. 
A key observation was that CV for Co(bpy)3
3+ in the absence of acrylonitrile showed the 
reduction sequence Co(III) → Co(II) → Co(I) → Co(0) → Co(-I). Reversible behavior was 
observed with the first 2 peaks at all sweep rates76. The third peak showed reversible behavior at 
moderate scan rates (1 V/s) .When acrylonitrile was added to the solution of Co(bpy)3
3+ , a new 
peak was observed76.  
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The magnitude of this peak does not go beyond that of the two separate peaks correlating to the 
reduction of Co(I) to  Co(0) and Co(0) to Co(-I). This peak decreases at the same rate as the new 
peak increases.  
Background on CV of nitrosobenzene 
A paper by Lessard and coworkers studied the behavior of nitrosobenzene, nitrobenzene, 
azoxybenzene, azobenzene on Hg, Pt, Cu, and Ni electrodes77. The working electrode used was a 
dropping mercury electrode (DME) or hanging drop mercury electrode (HDME). The reference 
electrode used was a silver wire immersed in an acetonitrile/TEAP (0.1 M)/AgNO3 (0.05 M) 
solution77. The reversible PhNO /PhNO+ redox couple gives peaks at -1.39 V vs. Ag/ AgNO3 
(0.05 M) and 1.32 V (Ep = 70 mV)77.  
Another paper by Bard and coworkers studied the electrochemical reactions of 
nitrobenzene and nitrosobenzene in liquid ammonia78. The reference electrode used was Ag wire, 
and the working electrode used was Pt foil coloumetric electrode.The supporting electrolyte was 
potassium iodide. Nitrosobenzene was reduced in 2 reversible one-electron steps78. For the 
electrochemical behavior of nitrosobenzene in the presence of isopropyl alcohol, the first 
reduction peak potential is not affected by the addition of isopropyl alcohol. However, in the 
case of the second reduction peak there is a reduction of peak with increasing concentration of 
isopropyl alcohol78. A key observation is further addition of isopropyl alcohol results in the 
shifting of peak to the positive direction, but no prominent increase in the peak current78. The 
peak potential of the new reduction wave does not depend on the scan rate. This shows that the 
rate of protonation of the dianion is very fast. Ep is a measure of the equilibrium constant for 
the protonation reaction.  
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(b) Experimental section 
   The cyclic voltammetry experiments were done in collaboration with Dr. Mekki Bayachou 
and Dr. Joseph Mundell. The pseudo- reference electrode used was metallic silver.  An internal 
standard- ferrocene was used to compensate for the use of a pseudo- reference electrode.   
The working electrode was Pt (platinum) and the counter electrode used was Pt. electrolyte used 
was 0.1M tetra-n-butylammonium hexaflurophosphate (Bu4NPF6). The electrolyte solution was 
degassed and dried using molecular sieves. The solvent used was N,N-dimethylformamide (DMF) 
due to the good solubility of both the electrolyte and the analyte in it. The working electrode was 
polished using a alumina water slurry on a polishing pad. 0.346g of electrolyte was dissolved in 
DMF was degassed for 10 minutes in a glass cell and then a background scan was performed. After 
the background scan was done, the cobalt complex 0.036g of [Co{Ph(O)NN(O)Ph}4](PF6)2 (3 
.013mmol) was added to the electrolyte and solvent solution and the whole solution (electrolyte, 
solvent, and cobalt complex) was stirred to make sure the complex was all well dissolved in 
solution. The internal standard used was ferrocene. The parameters used in the experiment are 
shown in Table VII. 
Segments 3 
Initial potential -500 mV 
direction moving to a more negative potential 
Upper potential 1000 mV 
lower potential -2500 mV 
final potential -500 mV 
Sweep rate 100mV/s 
Table VII: CV parameters for the cobalt complex 
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(c) Results and Discussion 
The cyclic voltammogram of the cobalt complex is shown in Figure 41.  
 
Figure 41: CV of cobalt complex 
The cyclic voltammogram is a plot of current (in μA) vs. potential (in V). A1 and C1 
show the first anodic-cathodic couple. A2 and C2 show the second anodic-cathodic couple.  The 
direction of the cyclic voltammogram starts from -0.5V and moves counterclockwise (initial 
reduction), as shown by the arrow in Figure 44. Based on EPR results (section 5.3), it can 
bepredicted that. that A2 and C2 are the Co(II)/Co(I) couple. A2 and C2 could be either Co 
(I)/Co(0), irreversible because of coupled dissociation of PhNO, or reduction of PhNO 
dissociated from Co(I).  However, more work needs to be done to assign these peaks with 
confidence. The potential and current at A1 are -1.188 V and 6.083 A, respectively. The 
potential and current at C1 are -1.478 V and -57.30 A, respectively. The potential and current at 
A2 are 0.7194 V and 28.81 A, respectively .The potential and current at C2 are -1.244 V and -
68.82 A, respectively.  
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The cyclic voltammogram of the cobalt complex with ferrocene internal standard is shown in 
Figure 42.  
 
  
 
 
 
 
 
 
 
Figure 42: CV of cobalt complex+ferrocene. 
 Ferrocene is used as an internal standard for reproducibility. Also in this case, the peaks 
of the cobalt azodioxide complex do not overlap with the peaks of ferrocene. The anodic and 
cathodic pair of ferrocene is shown in Figure 45. The potential and current of the anodic pair of 
ferrocene are 0.7703 V and 120.7 A, respectively. The potential and current of the cathodic pair 
of ferrocene are 0.4255 V and -72.13 A, respectively.  
The cyclic voltammogram of the monomeric form of the ligand- nitrosobenzene is shown in 
Figure 43.  
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Figure 43: CV of monomeric form of the ligand –nitrosobenzene 
The anodic and cathodic pair is shown in Figure 46. The potential and current at the anode are -
0.3015 V and 215.2 A, respectively. The potential and current at the cathode are 1.334 V and - 
323.2 A, respectively. There is an ohmic drop seen at approximately -0.3 V. Ohmic drop has 
been explained in chapter III (materials and methods).  
The cyclic voltammogram of monomeric form of the ligand-nitrosobenzene+ferrocene is shown 
in Figure 44.  
 
   Figure 44: CV of monomeric form of the ligand-nitrosobenzene+ferrocene 
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The cyclic voltammogram in Figure 47 shows the anodic and cathodic pair of ferrocene.  
Bracketing technique-:  In this technique there was a change in the lower potential from 
2500 mV to -1750 mV. This technique was performed in order to make sure that CV measurements 
were performed within the range of potentials in which the solvent is neither oxidized nor reduced. 
The cyclic voltammogram of the cobalt complex with a change in lower potential is shown in 
Figure 45. 
 
Figure 45: CV of the cobalt complex with change in lower potential (bracketing) 
The cyclic voltammogram of the cobalt complex by the bracketing is shown in Figure 48.  
Sweep rate and Randles-Sevcik equation  
Sweep rate is important because it controls the speed of the applied potential 73.Sweep rate 
is defined as the rate of change of applied potential.  The Randles- Sevick equation predicts that, 
for a reversible system, there is a linear relationship between the peak current and the square root 
of the sweep rate. Reversibility indicates if the complex is stable upon reduction and can be 
reoxidized later Reversibility determines the electron transfer kinetics between the complex and 
electrode 
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Reversible reactions do not have coupled homogeneous reactions that are fast on the experiment’s 
time scale.  
The Randles- Sevick equation is73- 
𝑖𝑝 = 0.4463 (
𝐹3
𝑅𝑇
)
1/2
𝑛3/2𝐴𝐷1/2𝐶∗𝑣1/2 
Where ip = peak current 
n = number of electrons transferred to the redox event 
electrode surface area 
D = diffusion coefficient of the analyte  
C*:  bulk concentration of the analyte 
v = sweep rate 
To determine, reversibility, the plot of square root vs the current (cathodic and anodic) should be 
linear73. The plot of current vs square root of sweep rate is shown in Figure 46. 
 
Figure 46: Plot of current vs sweep rate 
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The graph of square root of sweep rate vs current (cathodic and anodic) is not linear which 
indicates irreversibility73. This means that the system is not diffusion- controlled. Irreversibility is 
due to coupled homogeneous reactions75. This may be possible because of ligand coming off the 
cobalt complex, since the cobalt complex has a coordination number of eight 49, and usually cobalt 
complexes have a coordination number of 676.  
  Further experiments need to be performed to determine if the cobalt complex shows metal 
based or ligand based redox activity. Also further experiments need to be done to study the 
irreversible system.  Further experimental details are mentioned in (Chapter V111- Future 
directions).  
5.3 Electron Paramagnetic Resonance (EPR) spectroscopy 
The basics, experimental and collaboration details are explained in Chapter 1V. The EPR 
spectrum of [Co{Ph(O)NN(O)Ph}4](PF6)2 is shown in Figure 47.    
 
Figure 47: EPR spectrum of the cobalt azodioxide complex 
The cobalt complex was reacted with cobaltocene (Cp2Co) as a reducing agent and nitrosonium 
tetrafluoroborate (NOBF4) as an oxidizing agent. The oxidizing and reducing agent were chosen 
as they are fairly strong reducing and oxidizing agents and often participate in simple electron-
transfer reactions without modification of the covalent bond system of a molecule. 50.0 mg of the 
cobalt complex was dissolved in 10 mL acetonitrile (MeCN) to make a solution with Co complex 
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concentration of of 0.00415 M (4.15mM). 4.8 mg of NOBF4 was dissolved in 10 mL 
dichloromethane (DCM), and 7.8 mg of cobaltocene was dissolved in 10 mL DCM. These 
concentrations were chosen because when the reagents would be mixed a 1:1 ratio of MeCN and 
DCM, which gives a good ("glass" for low-temperature EPR). These reagents were mixed in a 
glove bag at Miami University. The EPR spectrum was recorded at 4.5K. The EPR spectrum of 
the cobalt complex + cobaltocene is shown in Figure 48. 
 
Figure 48: EPR spectrum of the cobalt complex+cobaltocene( stoichiometric amounts)  
The differences in the spectrum can be seen in terms of signal intensity. The signal intensity 
of the cobalt complex+ cobaltocene shows a decrease by a factor of about 3 compared to the EPR 
spectrum of the cobalt complex. 
This indicates an incomplete reaction with 1 equivalent of cobaltocene. However, when 
the cobalt complex was reacted with an excess of cobaltocene , all the EPR signals of the cobalt 
complex disappear, with no new EPR signals except that from unreacted cobaltocene.  
This is a strong indication that the cobalt complex, which is a high-spin Co (II) species, is reduced 
to a diamagnetic, low-spin Co (I) species with no unpaired electrons77, which, as a diamagnetic 
species, does not give an EPR signal The EPR spectrum of the cobalt complex+ excess cobaltocene 
is shown in Figure 49.  
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Figure 49: EPR spectrum of the cobalt complex+ excess cobaltocene 
The EPR spectrum of the cobaltocene is shown in Figure 50. 
 
Figure 50: EPR spectrum of cobaltocene 
The EPR spectrum of cobalt complex+ NOBF4 is shown in Figure 51. 
 
Figure 51: EPR spectrum of cobalt complex+NOBF4 
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In this EPR spectrum it can be seen that the signal intensity of the cobalt complex with 
added NOBF4 is the same as that of the signal intensity of the cobalt complex. This indicates that 
there is no reaction between the cobalt complex and NOBF4. This indicates that NOBF4 is not a 
strong enough oxidizing agent to oxidize the Co complex. The EPR spectrum of NOBF4 was not 
taken since, it has no unpaired electrons. A stronger oxidizing agent that might yield reaction is 
potassium permanganate (KMnO4). However, oxidizing agents such as KMnO4, which participate 
in oxygen atom transfer in addition to electron transfer, could form a more complex mixture of 
products and yield an EPR spectrum that is difficult to interpret78. 
Based on the EPR experiment data, it does not appear that NO+ can oxidize the cobalt 
complex, but the reduction of the cobalt complex suggests a higher possibility of being metal-
based, rather than ligand-based. This is because reaction with excess cobaltocene essentially 
removes the EPR signal. This result can be rationalized by the reduction of high-spin Co (II), with 
3 unpaired electrons, to low-spin Co (I), with no unpaired electrons77. If the reduction were ligand-
based, then a new unpaired electron would be generated on one of the ligands, and we would still 
expect to see an EPR signal.  
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CHAPTER VI 
ALLYLIC AMINATION /C-C DOUBLE BOND TRANSPOSITION  
6.1 Reaction scheme 
        The allylic amination/C-C double bond transposition using [Co{Ph(O)NN(O)Ph}4](PF6)2 as 
a catalyst is shown in Figure  5240. 
 
Figure 52: Allylic amination/C-C double bond transposition using [Co{Ph(O)NN(O)Ph}4](PF6)2 
as a catalyst 40.  
6.2 Procedure  
The reaction set up was done in a glove box. 3.2 mmol of the alkene 2-methyl-2-pentene 
(0.269 g) of alkene was dissolved in 5 mL acetonitrile and added to a Schlenk tube. 10 mol% 
(0.121g)of the catalyst Co{Ph(O)NN(O)Ph}4](PF6)2 was dissolved in 10 mL acetonitrile and added 
to the alkene solution. Then 1.4mmol (0.16g) of phenylhydroxylamine dissolved in 5ml 
acetonitrile was added slowly. The reaction was run under heat in a closed Schlenk tube at 75 0C 
for 72 hours. The solvent was then removed under vacuum, and the solid was dissolved in diethyl 
ether40.  Reaction monitoring was done using thin layer chromatography (TLC).The solvent system 
used was petroleum ether and diethyl ether. 
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The purification was done using column chromatography and the solvent system used 
was petroleum ether and diethylether.40. The same procedure was repeated for 2-methyl-2-
hexene (0.3142 g was used instead of 0.269 g). These 2 alkenes were chosen because Nicholas 
and coworkers40 got highest yields with these 2 alkenes. Nicholas and coworkers 40 used dioxane 
as the reaction solvent. However, we got better results using acetonitrile as the reaction solvent. 
Out of the 2 alkenes, good results were obtained with 2-methyl-2-pentene. Therefore, further 
discussion will pertain to 2-methyl-2-pentene. The limiting reagent was phenylhydroxylamine.  
The yield obtained was 40%. The catalytic turnover number is defined as the total number of 
moles of product/moles of catalyst 79. Therefore, using this formula, 40% yield/10% mol catalyst 
= 4, giving a turnover number of 4.  
6.3 Results and Discussion 
The GC-MS was done on the crude product (before column chromatography).However 
there was a minor silica gel pipette column purification performed to remove the cobalt metal. The 
injection volume was 1 μL, and the oven temperature was 290 0C. The column flow rate was 1 
mL/min.  The sample was run for 30 minutes. The products were identified using the extract 
chromatogram feature.  The mass spectrum of the products obtained by the allylic amination/C-C 
double bond transposition reaction is shown in Figure 5340 
  
Figure 53: Mass spectrum of the products obtained by allylic amination reaction 
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The region in red with a m/z ratio of 175.136 is the major product40. The side products are 
shown in purple and orange lines at m/z ratio of 182.1, and 198.0 respectively40. The product with 
the purple line is azobenzene and the product with the orange line is azoxybenzene.  
The chemical structures, exact mass and m/z of these products are shown in Figure 54 40.  
 
Figure 54: Chemical structures , exact mass and m/z of products 
Since GC-MS differentiates between compounds based on m/z ratio, the relative 
abundances of isotopes play a pivotal role80. Each isotopic composition shows as a distinct line in 
the mass spectrum. Due to this reason, the height of each peak corresponds to relative abundance 
of each isotopic composition in the sample80. This is the reason for the differences in m/z shown 
in the figure 54. 
NMR experimental section and results 
The frequency of the instrument used was 400MHz, and the solvent used for sample 
preparation was deuterated chloroform (CDCl3)
40.  
 (a) NMR spectroscopy of product C12H17N 
The structure corresponding to C12H17N is shown in Figure 55
40.  
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Figure 55: Structure corresponding to C12H17N 
40 
The NMR spectrum of the product (C12H17N) is shown in Figure 56
40, 81.  
 
Figure 56: NMR spectrum of the product (C12H17N).  
Table VIII shows the chemical shifts and the corresponding functional groups as seen in Figure 
61.  
Chemical shift(ppm) Functional group 
3.0 Amine 
6.0,7.0 Aromatic 
1.0,2.0, and 5.0 Alkene 
Table VIII: Chemical shifts and corresponding functional groups of (C12H17N) 
The NMR spectrum of each individual area is discussed in detail. The NMR spectrum of the 
aromatic region (ortho) in the product C12H17N is shown in Figure 57
40, 81 
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Figure 57: NMR spectrum of the aromatic region (ortho) in the product (C12H17N)
 40, 81  
The ortho hydrogens are shown in black in the spectrum. The ortho hydrogens are 
chemically equivalent and appear in the chemical shift of 6.84ppm. The number of hydrogens is 2 
which is indicated by the integration number (1.9729) rounded off to the nearest whole number. 
The peak obtained is a multiplet. The spectrum was compared to a literature spectrum 40, 81. 
The NMR spectrum of the aromatic region (meta) in the product (C12H17N) is shown in Figure 58.  
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Figure 58: NMR spectrum of the aromatic region (meta) in the product (C12H17N)
 40, 81     
The meta hydrogens are shown in blue- gray in the spectrum. The meta hydrogens are 
chemically equivalent and appear in the chemical shift of 7.38ppm. The number of hydrogens is 2 
which is indicated by the integration number. The peak obtained is a multiplet. The spectrum was 
compared to a literature spectrum40, 81. The chemical shift values reported were close to the 
experimental values. 
The NMR spectrum of the aromatic region (para) in the product (C12H17N)
 is shown in Figure 59.  
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Figure 59: NMR spectrum of the aromatic region (para) in the product (C12H17N)
 40, 81 
    The para hydrogen is shown in purple in the spectrum.  The para hydrogen appears in the 
chemical shift of 6.91 ppm. The number of hydrogens is 1 which is indicated by the integration 
number (0.9872) rounded off to the nearest whole number. The peak obtained is a multiplet. The 
spectrum was compared to a literature spectrum 40, 81.  The chemical shift values reported were 
close to the experimental values.  
The arrangement of hydrogen atoms attached to carbon 1 in the alkene region of the product 
(C12H17N) are shown in Figure 60
40.  
       
Figure 60: Hydrogen atoms attached to carbon 1 in the alkene region of the product (C12H17N) 
The regions of the NMR spectrum corresponding to the geminal hydrogen atoms of carbon 1 in 
the alkene region of the product (C12H17N) are shown in Figure 61
40, 81. 
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Figure 61: NMR spectrum of geminal hydrogen atoms of carbon 1 in the alkene region of the 
product (C12H17N) 
 
The hydrogens attached to carbon1 in the alkene of the product are shown in blue and blue-
gray. The hydrogens in region 1 are not chemically equivalent since they are geminal hydrogens.  
The coupling of two hydrogen atoms on the same carbon is referred to as geminal coupling82 .The 
geminal hydrogen atoms on carbon 1 will split each other to form two doublets.  
    Since the hydrogens on carbon 1 are not equivalent, the splitting pattern seen is 2 separate 
doublets at chemical shifts of 5.14 ppm and 5.33 ppm respectively. The lower chemical shift 
(hydrogen marked blue, 5.14 ppm) has been assigned because this hydrogen is more shielded 
which has been discussed in this chapter earlier81. This hydrogen is more shielded because it is 
closer to alkyl groups. The higher chemical shift (hydrogen marked blue- gray, 5.33 ppm) has been 
assigned to this hydrogen because this hydrogen is more deshielded since it is closer to the amine 
group which is more electronegative compared to alkyl groups81.The integration shows 1H for 
each chemical shift. The coupling constant (J) value was calculated using excel by computing 
chemical shifts, multiplicity and frequency of the NMR instrument. The J value for the blue 
hydrogen is 7.3Hz and the J value is 8.0Hz for the gray hydrogen.  
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The structure of hydrogens attached to carbon 2 in the alkene region of the product (C12H17N) are 
shown in Figure 6240. 
 
Figure 62 : Structure of hydrogens attached to carbon 2 in the alkene region of the 
product(C12H17N) 
 
The NMR spectrum of hydrogen atoms attached to carbon 2 in the alkene region of the product 
(C12H17N) are shown in Figure 63
40, 81. 
 
Figure 63: NMR spectrum of hydrogens attached to carbon 2 of alkene region of product 
The methyl hydrogens (blue) in the NMR spectrum have a chemical shift of 1.66 ppm 
which is within the range expected for methyl hydrogens. approximately the chemical shift 
reported for methyl group 40, 81. The integration indicates that there are 3 hydrogens.  
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The structure of hydrogen attached to carbon 3 and the neighboring hydrogens on carbon 4 in the 
alkene region of the product (C12H17N) is shown in Figure 64
40 
 
Figure 64: Structure of hydrogen attached to carbon 3 and the neighboring hydrogens on carbon 4 
in the alkene region of the product (C12H17N)  
The NMR spectrum of hydrogen attached to carbon 3 in the alkene region of the product (C12H17N) 
are shown in Figure 65.   
 
   Figure 65: NMR spectrum of hydrogen attached to carbon 3 in the alkene region of product 
 
The hydrogen attached to carbon 3 in the alkene region of the product is shown in green. 
The neighboring hydrogen atoms attached to carbon is shown as 4 (brown). There are 2 chemically 
non- equivalent hydrogens (diastereotropic hydrogens). More about diastereotropic hydrogens will 
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be seen during the discussion of hydrogens on carbon 4. Therefore, using the N + 1 rule, for each 
of the hydrogens separately the splitting obtained should have been a doublet of doublets (1+1=2 
for one hydrogen, and 1+1=2 for the other hydrogen). However, a triplet is seen because the 
coupling constants of the chemically non-equivalent hydrogens are close enough. The J avg 
calculated was found to be 7.5 Hz. Also the frequency of the NMR instrument used is 400MHz, if 
a NMR spectrometer with a very high resolution like 1000MHz were used, a doublet of doublets 
should be seen82. Carbon 3 is also a chiral carbon. A chiral carbon is a carbon which is connected 
to 4 different atoms or groups of atoms83 .The chemical shift value is 4.03 ppm. The number of 
hydrogens indicated by the integration is 1. The J value was found to be 6.6Hz.  
The structure of the hydrogen atoms attached to carbon 4 in the alkene region of the product are 
shown in Figure 70 previously.  
The NMR spectrum of hydrogens attached to carbon 4 in the alkene region of the product 
(C12H17N) are shown in Figure 66
40, 81. 
 
 Figure 66: NMR spectrum of hydrogens attached to carbon 4 in the alkene region of the product  
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The hydrogens attached to carbon 4 of the alkene of the product are shown in brown. The 
asterisks indicate that both the hydrogens are not chemically equivalent. The hydrogens are not 
chemically equivalent because they are diastereotropic hydrogens, since carbon 4 is next to carbon 
3(shown in green), and carbon 3 is a chiral carbon as mentioned in the section for carbon 3. 
Diastereotropic hydrogens are present in diastereomers84. Diastereomers are non-superimposable 
and not mirror images of each other84.The multiplet (quintet) is not due to the  N+1 rule, but due 
to limited spectral resolution85.   The chemical shift is 2.02 ppm. The integration shows that there 
are 2 hydrogens. The Javg value has been shown in the explanation of the NMR spectrum for carbon 
3.  
The structure of hydrogens attached to carbon 5 and the neighboring carbon 4 in the alkene region 
of the product (C12H17N) are shown in Figure 67
40. 
 
Figure 67: Hydrogens attached to carbon 5 and the neighboring carbon 4 in the alkene region of 
the product (C12H17N) 
The NMR spectrum of hydrogens attached to carbon 5 in the alkene region of the product are 
shown in Figure 68.  
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Figure 68: NMR spectrum of hydrogens attached to carbon 5 in the alkene region of the product 
(C12H17N)
 40, 81 
   The hydrogens attached to carbon 5 in the alkene region of the product are shown in purple, the 
neighboring hydrogens attached to carbon 4 (brown) has 2 chemically non-equivalent hydrogens, 
So the N +1 rule for each of the hydrogens should result in a doublet of doublets similar to carbon 
3. However again a triplet is seen because the coupling constants on carbon 4 are close enough 
(Javg). Also due to limited spectral resolution a triplet is seen.  The chemical shift is 1.00 ppm. The 
integration shows 3 hydrogens. The J value was found to be 7.6Hz. 
The NMR spectrum of the amine region of the product (C12H17N) is shown in Figure 69
40,81. 
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          Figure 69: NMR spectrum of the amine region of the product (C12H17N) 
40, 81 
         The amine region (shown in red) has a chemical shift of 3.34ppm. The splitting pattern is a triplet.    
 
 
 
.  
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CHAPTER V11 
[Co{Ph(O)NN(O)Ph}4](PF6)2 AS A POTENTIAL DRUG FOR CANCER TREATMENT 
7.1 Apoptosis  
Apoptosis is the process in which, when cells are no longer required or have undergone 
irreparable DNA damage, they “commit suicide” by the activation of a cellular death program86. 
Apoptosis is also referred to as programmed cell death86. Apoptosis is important because cell 
death balances cell division86.  This is necessary to maintain the size of the tissue. For example, 
if tissue were removed from a rat’s liver, liver cell proliferation would increase to compensate 
for the loss87. Cells that go through apoptosis die without harming the neighboring cells. The cell 
condenses and diminishes, and the DNA divides into fragments 87 .The cell surface is modified, 
showing properties that are responsible for the dying cell to be rapidly phagocytosed/engulfed, 
either by an adjacent cell or by a macrophage87.  
In contrast to apoptosis, there is another type of cell death known as necrosis. Necrosis is 
often referred to as accidental death88.  Necrosis occurs due to external factors such as infection, 
trauma or toxins89. Necrosis is harmful because uncontrolled cell death leads to the release of 
harmful enzymes into nearby tissue. The released contents of necrotic cells provoke an immune 
response leading to inflammation. Pyknosis is observed in necrosis which is characterized by 
nuclear shrinkage90.  Condensation of chromatin precedes the nuclear shrinkage.  Pyknosis is 
followed by karyorrhexis, in which the nucleus undergoes fragmentation and then departs the 
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necrotic cell 91. .Necrosis does not involve any protein synthesis and does not require any 
homeostatic processes. Therefore, it is generally considered to be a passive process. It is 
interesting to note that many diseases such as Alzimher’s disease, Hungtington’s disease, and 
epilepsy involve necrosis 92. Necrosis is responsible for many of the symptoms of these diseases.  
7.2 Major proteins involved in apoptosis 
p53: The potential of p53 to remove damaged or infected cells by apoptosis is important for 
the correct regulation of cell proliferation91. External and internal stress signals that assist the 
nuclear accumulation of p53 in active form activate p53. p53 either cause apoptosis, or viable 
cell growth arrest91. The functions of p53 consist of DNA differentiation, repair, and 
angiogenesis (the formation of blood vessels).  
Bcl-2: Bcl-2 is an important “gatekeeper” of the apoptotic response92. Bcl-2 consists of 
structurally related proteins consisting of pro-apoptotic and anti-apoptotic proteins. The anti-
apoptotic members of the Bcl-2 family stop apoptosis by segregating caspases or by prevention 
of activation of cytochrome c92. The pro-apoptotic membranes generate the release of caspases 
by inducing the release of mitochondrial apoptogenic factors into the cytoplasm92.   
PARP: Poly (ADP-ribose) polymerase (PARP) enzymes have the function of DNA repair93. 
The PARP family consists of 17 members93. Among the 17, PARP-1 is the most abundant, and its 
role is a DNA damage sensor. PARP is made up of 4 domains of interest: a DNA binding domain, 
a caspase-cleaved domain, a catalytic domain, and an auto-modification domain. The DNA 
binding domain binds to DNA and causes a conformational change93 . PARP is useful in the 
repair of single-strand DNA repair nicks. PARP uses NAD+ as the substrate in order to adjust 
acceptor proteins with ADP-ribose functions93.  
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Caspase:   There are 14 types of caspases94. Caspases 8, 9 and 3 are present at important 
junctions in apoptosis pathways. Caspases are generated as inactive, monomeric procaspases that 
are dimerized and cleaved for activation .Caspases 8 and 9 are procaspase monomers which are 
activated by dimerization94. Caspases 3, 6, and 7 act as executioner caspases. The executioner 
caspases break down parts of the cells in apoptosis, therefore the name.  The cleavage between 
large and small subunits causes a conformational change and brings two active sites of the 
executioner caspase together.  
TNF: Tumor necrosis factor (TNF) triggers both cell-survival and cell-death mechanisms. TNF 
applies its many effects through two receptors95: TNFR1, which is the main signaling receptor 
for the introduction of cell death and gene regulation; and TNFR2, which signals cell 
proliferation, gene activation and apoptosis mainly in T cells95 
7.3 Apoptotic pathways 
There are 2 pathways- extrinsic and intrinsic. The pathways are shown in Figure 70.  
 
Figure 70: Extrinsic and intrinsic apoptosis pathways 
In the extrinsic pathway the death complex is formed by the activation of receptors by the 
death ligands113. The term “ligand” here are used in a different context than in coordination 
chemistry. In this biochemical context, a ligand is defined as a substance which has the ability to 
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form a complex with a biomolecule, which results in serving a biological purpose 113. Death 
ligands cause the activation of caspase-8. In the intrinsic pathway, cellular stress causes 
mitochondrial dysfunction,  with the release of cytochrome c into the cytoplasm 113  . This forms 
an activation complex with caspase-9. Caspase-9 then cleaves caspases 3, 6, and 7.  
7.4 Role of apoptotic proteins in cancer treatment 
Apoptosis plays a pivotal role in cancer treatment90. In cancer, there is uncontrolled cell 
growth and avoidance of apoptosis by the cancer cells. Cancer treatments cause cancer cells to 
undergo apoptosis, triggering death signals by causing DNA damage. An important mechanism 
of anti-cancer drugs is to change the cancer cells’ the apoptotic signaling pathways towards a 
normal function.  Apoptosis is established within hours after cytotoxic treatment and is 
dependent on the dose of the chemotherapeutic agent96. Some drugs target Bcl-2 genes112. One 
such example is oblimersen sodium, which is the first drug to enter clinical trials that has shown 
chemosensitizing effects in combined treatment with regular anti-cancer drugs. The Bcl-2 
inhibitor drugs can be divided into two categories: drugs that act on proteins, and drugs that 
affect protein expression. There is a wild-type p53 gene that has proven to stimulate tumor cells 
of colorectal and prostate cancer. Many drugs have been shown to target p53 by different 
mechanisms. One category of drugs can bind and restore mutant p53 back to their wild-type 
functions. Another category intercalates with DNA and destabilize the DNA p53 core domain 
complex.  
7.5 Examples of compounds that induce apoptosis and their relation to cancer therapy 
Cisplatin:  Cisplatin has a similar mechanism like alkylating agents. In cisplatin guanine 
N7 atoms are bound to Pt. The mechanism of cisplatin as an anticancer drug is by p53 
activation99. The stability and transcriptional activity is found to be regulated by two kinases: 
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ataxia telangiectasia-mutated protein (ATM), and ATM- and Rad3-related protein (ATR) 99.  
Cisplatin activates ATR kinase, which in turn phosphorylates p53 on serine-1599.  Out of all the 
mitogen-activated protein kinase signals, which include extra-cellular related kinases (ERK), c-
Jun N-terminal kinases (JNKs), and the p38 kinases, ERK activation appears to be the most 
significant. This is because activated ERK also phosphorylates p53 on serine-1599. There is also 
the activation of JNK/p38 which effects phosphorylation of transcription factors c-Jun .  This 
results in the activation of transcription factor (ATF-2)99 which bind to promoters of multiple 
target genes99. This cascade activates apoptosis99.  
Taxol: Taxol stabilizes the microtubules formed during cell division, and does not allow 
their disassembly100. For this reason, chromosomes are unable to attain a metaphase spindle 
configuration. This stops the advancement of mitosis and causes prolonged activation of the 
mitotic checkpoint, which in turn leads to apoptosis101. 
Doxorubicin: The main mechanism of action for doxorubicin consists of interaction with 
DNA by intercalation, and inhibition of macromolecular DNA synthesis102. Due to this 
intercalation, the advancement of topoisomerase II is inhibited. Topoisomerase II is an enzyme 
which is responsible for the relaxation of supercoils in DNA for transcription. Doxurubicin has 
the ability to stabilize the topoisomerase II complex after the DNA chain has been broken by 
topoisomerase II102. This stops the DNA double helix from being resealed, which halts the 
replication process.  
Anti-neoplastic alkylating agents: Examples of anti-neoplastic alkylating agents include 
carmustine, chlorambucil, streptozocin, and busulfan103. Their mechanism of action is the 
alkylation of two guanine residues at the N7 position. If these guanine residues are present in 
different DNA strands, then cross-linkage occurs, which prevents the uncoiling of the DNA 
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double helix. If the guanine residues are in the same strand the drug molecule is attached to the 
DNA104. Both these mechanisms prevent DNA-processing enzymes from accessing the DNA. 
The end result is apoptosis.  
7.6 Examples of cobalt compounds that induce apoptosis and its relation to cancer therapy 
       Arunachalam and coworkers91 found that the cobalt(III)-containing metallosurfactants cis-
[Co(bpy)2(C11H23NH2)Cl](ClO4)2·3H2O  and cis-[Co(phen)2(C11H23NH2)Cl](ClO4)2·3H2O bind 
to DNA of HBL-100 human breast cancer cells. Apoptosis was observed for both the 
compounds. Apoptosis was better in cis-[Co(phen)2(C11H23NH2)Cl](ClO4)2·3H2O based on IC50 
values. (IC50 is the half maximal inhibitory concentration, and is a measure of potency of a 
substance in preventing a particular biochemical or biological function). The IC50 for  
cis-[Co(phen)2(C11H23NH2)Cl](ClO4)2·3H2O was reported to be 20-25 µM after 24 h, 5-10 µM 
after 48 h compared to cis-[Co(bpy)2(C11H23NH2)Cl](ClO4)2·3H2O  complex (IC50 45-50 µM 
after 24 h, 15-20 µM after 48 h). Another study by Arunachalam and coworkers 92showed that 
Co (III) complex [cis-Co(trien)(4CNP)(DA)](ClO4)3, where trien = triethylenetetramine, 4CNP = 
4-cyanopyridine, and DA = dodecylamine, induced apoptosis in HepG2 liver cancer cells.  
Satyanaryana and coworkers 93 showed the Co (III) complexes:  
[Co(phen)2(PIP-Br)](ClO4)3, [Co(bpy)2(PIP-Br)](ClO4)3, and [Co(dmb)2(PIP-Br)](ClO4)3, 
where dmb = 4,4-dimethyl-2,2´-bipyridyl  
 and PIP-Br = 2-(4´-bromophenol)imidazo[4,5-f][1,10]phenanthroline,. The complexes induced 
apoptosis and were cytotoxic to SKOV3 (ovarian cancer) cells with 48 h exposure. Govindarajan 
and coworkers94 found that [Co(NCS)2(L1)2], [Co(NCS)2(L2)2], [Co(NCS)2(L3)2],  
where L1 = benzyl 2-(cyclobutanylidene)hydrazonecarboxylate,  
L2 = benzyl 2-(cyclopentanylidene)hydrazinecarboxylate, and 
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L3 = benzyl 2-(cyclohexanylidene)hydrazinecarboxylate, induced apoptosis and were cytotoxic 
to K-562 leukemia cells. Another study by Tan and co-workers 95 showed that the Co (III) 
complex [CoL2](ClO4)3,  
 where L = N,N-diethyl-4-(2,2´:6´,2´´-terpyridin-4´-yl)aniline, induced apoptosis and may 
activate caspase-3 and caspase-9.  
Another study by Tabrizi and co-workers 97showed that M(phen)(Jug)2, where M = Co, Ni, Cu, 
and Jug = juglone = 5-hydroxy-1,4-napthalenedione, induced apoptosis. Antiproliferative activity 
was observed against HeLa (cervical cancer), HepG-2 (liver cancer), and HT-29 (colorectal 
adenocarcinoma). The cobalt complex has higher IC50 value as compared to the copper complex, 
but less than cisplatin.  
7.7 Introduction to western blot 
      Western blot helps in the identification of particular proteins from a complex mixture of 
proteins extracted from cells98.  The basic principle involves the separation by size, transfer to a 
solid support, and identification of the target protein by antibodies. In order to separate proteins, 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) is used to separate 
various proteins in a sample98.  In the next step, the separated proteins are transferred onto a 
membrane which is generally a nitrocellulose membrane or Polyvinylidene difluoride (PVDF). 
Later they are stained with antibodies specific to the target protein98.  The expression of the 
proteins can be obtained by analyzing the location and intensity of the specific reaction.  
7.8 Experimental section 
    The experiments were done in collaboration with Dr. Aimin Zhou and Ms. Norah 
Alghamadi. The cobalt complex [Co{Ph(O)NN(O)Ph}4](PF6)2 (0.051 g , 0.042mmol) was  
dissolved in 10 mL dimethyl sulfoxide (DMSO) and tested on lung cancer cells (A549), colon 
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cancer cells (HT29), and liver cancer cells (SK-HEP1). Out of all these cells, apoptosis was only 
found in liver cancer cells (SK-HEP1). SK-HEP1 is an endothelial cell type99. SK-HEP1 cells 
were cultured in a 6-well plate, and when they were 80-90% in confluence, the cells were treated 
with the cobalt complex for 12 hours.  Confluence in cell biology means the percentage of a 
surface of a culture dish that is covered by adherent cells99.  Media was: Dulbecco's Modified 
Eagle Medium (DMEM), serum- fetal bovine serum (15%FBS), and Penicillin-streptomycin 
solution (1% P/s). 
    Photographs of the unstained cells (SK-HEP1) were taken of the control (untreated cells), cells 
with just DMSO (without the cobalt complex), and cells treated with the cobalt complex solution 
(concentrations of 1 µM, 2 µM, 5 µM, and 10 µM) were taken with a microscope (Olympus 
model CKX31 at 40X magnification). For western blot analysis, after 12 hours of treatment, 
(SK-HEP1) cells were collected and total protein was extracted with HEPES lysis buffer with 
protease inhibitors. Cells (SK-HEP1) were sonicated, then centrifuged for 20 minutes at 12 rpm 
at 4 degree Celsius. 70 µg of protein was loaded to sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) and western blot analysis was performed using primary and 
secondary antibodies.  A primary antibody is the antibody that binds directly to the antigen100. 
The function of the primary antibody is to identify an epitope on the antigen. An epitope is the 
specific target against which an individual antibody attachesref. The primary antibody lacks a 
fluorophore or an enzyme. Therefore, to visualize the antigen a secondary antibody is needed100. 
The secondary antibody binds to the primary antibody100. The secondary antibody is prepared in 
a species different from the primary antibody and the specimen of interest100. The primary 
antibodies used in this experiment were- poly (ADP-ribose) polymerase (PARP) and 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The dilution of the antibodies to buffer 
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was 1:1000 which means for 10ml of buffer, 10µL of antibodies were added. The buffer is called 
the blocking buffer100. Blocking buffer is composed of 3-5% milk or bovine serum albumin100.  
The secondary antibodies used were –anti- mouse for GAPDH (primary antibody) and anti-rabbit 
for PARP (primary antibody). All the antibodies used were from cell signaling technologies. The 
primary antibodies and the membrane, (explained in the western blot section) were incubated 
overnight, then the membrane was washed and incubated with the secondary antibodies (dilution 
for secondary antibodies: 1:2000) for one hour. The membrane used in this procedure was PVDF.  
Then there was a wash and the developing solution was added100. The developing solution used 
was horseradish peroxidase substrate (HRP). Then the film (ecomax X-ray film processor) was 
incubated for 1 min, and later processed 100. The film is a good technique to check if a protein is 
expressed by a particular cell line 
7.9Results and Discussion 
    The photographs of the untreated cells (SK-HEP1), cells treated with DMSO, and cells 
treated with different concentrations of the cobalt complex solution (1 µM, 2 µM, 5 µM, and 10 
µM) are shown in Figure 71.  
 
Figure 71: Photographs of cells (SK-HEP1), untreated, with DMSO and different concentrations 
of the cobalt complex solution (1 µM, 2 µM, 5 µM, and 10 µM) 
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The photographs show that cell death occurs with increasing concentrations of the Co 
complex. Cell death is demonstrated by a decrease in the number of cells.  There is a dose 
dependent cell death. The mechanism of cell death cannot be predicted by these photographs. 
Western blot can provide us with information about the mechanism of cell death. 
The western blot of the cells (SK-HEP1) (untreated control cells, cells treated with 
DMSO, and cells treated with 1 µM, 2 µM, 5 µM, and 10 µM of the cobalt complex solution) are 
shown in Figure 72101.  
 
Figure 72: Western blot of the cells (SK-HEP1) (untreated control cells, cells treated with 
DMSO, and cells treated with 1 µM, 2 µM, 5 µM, and 10 µM of the cobalt complex solution)101 
 
PARP is a stress-response protein with a molecular weight of 116 Da. PARP is an 
indicator of DNA repair101.  Cleaved PARP was detected, which indicates that apoptosis is 
occurring. Since PARP is responsible for DNA repair, when cells are undergoing apoptosis, 
PARP is not active, as there is no need to repair DNA in dying cells. GAPDH is a housekeeping 
protein used as a control. The western blot shows bands corresponding to cleaved PARP at 5 µM 
and 10 µM concentrations of the Co complex, which indicates apoptosis occurred at these 
concentrations.  
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7.10 Conclusion 
       It has been shown that the cobalt complex [Co{Ph(O)NN(O)Ph}4](PF6)2 has the ability to 
induce apoptosis in liver cancer cells (SK-HEP1) at 5 µM and 10 µM concentrations. More work 
needs to be done to determine the apoptotic pathway. In addition, to determine if the complex 
can be used as an anticancer drug, pre-clinical studies need to be done. The future directions are 
discussed in the next chapter (chapter V111).  
 
 
 
 
 
 
 
.  
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CHAPTER V111 
FUTURE DIRECTIONS 
8.1 Electrochemistry: Cyclic Voltammetry (redox activity) 
To determine if the electrochemical reduction of [Co{Ph(O)NN(O)Ph}4](PF6)2 is metal-
based or ligand-based, the following experiments are proposed based on a study by Barigelletti 
and coworkers102. These authors measured the half-wave reduction potentials E1/2(red) for 
complexes of the form Ru(N–N)2(N–N´)2+ and Ru(N–N´)32+, where N–N and N–N´ are aromatic, 
chelating nitrogen ligands like 2,2-bipyridyl (bpy) or 1,10- phenanthroline (phen), amenable to 
metal to ligand charge transfer (MLCT) due to their low-lying π-antibonding lowest unoccupied 
molecular orbitals (LUMOs), and N–N´ is easier to reduce (has a lower-energy LUMO) than N–
N. They also measured E1/2(red) for the free N–N´ ligands, and found a linear relationship 
between E1/2(red) for the N–N´ complexes and E1/2(red) for free N–N´. They interpreted this 
finding as supporting ligand-based reduction of the N–N´ complexes: if the ease of reducing the 
complex is so strongly correlated with the ease of reducing the free ligand, this result suggests 
that most of the complex reduction occurs on the ligand. Considering this study, preparation and 
characterization of complexes analogous to [Co{Ph(O)NN(O)Ph}4](PF6)2  
and [Co(bpy)( Ph(O)NN(O)Ph)2](PF6)2 whose azodioxide ligands have aromatic rings 
substituted with electron-donating groups or electron-withdrawing groups.  
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For instance, more electron-rich azodioxides could consist of the dimers of 4-nitrosoanisole (4-
NO-C6H4-OMe) or N,N-dimethyl-4-nitrosoaniline (4-NO-C6H4-NMe2), whereas more electron-
poor azodioxides could consist of the dimers of 4-nitrosonitrobenzene (4-NO-C6H4-NO2)  
or 4-cyanonitrosobenzene (4-NC-C6H4-NO)103. We would measure E1/2(red) for the free 
nitrosoarenes (not the free azodioxides, as azodioxides dissociate to monomers in solution), as 
well as for the Co complexes of the substituted azodioxides, and a linear relationship would 
suggest that reduction of the Co complexes would be largely occurring on the ligands. Based on 
the isolobal analogy of neutral azodioxides with dianionic dithiolenes39 (explained in chapter 
1V), the possibility of ligand-based oxidation also exists for azodioxide complexes: to assess 
whether ligand-based oxidation occurs, we would measure the half-wave oxidation potentials 
E1/2(ox) for both the free nitrosoarenes and their Co complexes, with a linear relationship 
suggesting ligand-based oxidation103. 
Another experiment proposed is spectroelectrochemistry, which involves the use of the 
cyclic voltammetry set up with a UV-Vis spectrometer. Spectroelectrochemistry is useful, since it 
provides an analysis of single and multiple electron- transfer processes and redox reactions104. 
Spectroelectrochemistry has a variety of applications in analytical chemistry, chemical biology, 
biophysics, materials science104. Spectroelectrochemistry involves spectroscopic investigation of 
an optically transparent electrode (OTE) .As it was seen in chapter VI, that an irreversible system 
was observed for the cobalt complex, spectrochemical reactions would be helpful in studying 
homogeneously coupled reactions and also could explain for the ligand loss. 
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8.2Catalysis            
Another azodioxide complex-catalyzed reaction has been proposed which is a nitroso-ene 
reaction similar to that of allylic amination/C-C double bond transposition previously shown in 
chapter V1. The nitroso-ene reaction is shown in Figure 73.  
 
Figure 73: nitroso-ene reaction 105 
In the nitroso-ene reaction, the hydrogen abstraction leading to major product formation 
generally occurs from the twix carbon as compared to the twin carbon or lone carbons. This is 
according to the mechanism involving diradical intermediates 105. Some nitroso-ene reactions 
have also shown to proceed through a concerted mechanism106.  Nitroso-ene reactions are not 
always metal-mediated, and nitroso compounds can directly react with alkenes containing allylic 
hydrogens106. There have been examples where transition metal complexes are used in this type 
of reaction106. The product obtained with transition metal as catalysts yields an allylic secondary 
amine compared to a hydroxylamine107.  The metal in this reaction is oxidized and the reaction is 
catalytic (as opposed to stoichiometric). 
The nitroso- ene reactions involving acyl-nitroso compounds are a distinct type of 
nitroso-ene reactions compared to the one mentioned in the previous paragraph. A reaction 
scheme showing the acyl nitroso type of nitroso- ene reaction is shown in Figure 74108.   
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Figure 74: acyl nitroso type of nitroso-ene reaction108 
The acylnitroso compounds are required to be generated in situ because of their 
instability, they cannot be isolated108 .The acyl nitroso synthesis involving transition metals have 
a problem because the acylnitroso compound reacts as a free species with its reaction partner, 
instead of being coordinated to the transition metal. This is a concern for enantioinduction 
because chiral and enantiopure ligands109 cannot be used. The use of chiral and enantiopure 
ligands are important since it helps to determine the formation of one enantiomer over the other. 
However the use of nitroso dimer complexes with chiral and enantiopure ligands would enable 
an enantioselective reaction which is a favorable synthetic strategy110. Enantioselective reactions 
are useful in synthesis of active pharmaceutical ingredients110. It is cost effective to produce a 
single enantiomer compared to the development work required for pharmacokinetic and 
toxicological profile of the rejected enantiomer110. Enantioselective catalysis provides an 
efficient synthesis by providing attainable chiral molecules not readily produced by nature111. 
[Co{Ph(O)NN(O)Ph}4](PF6)2 and [Co(bpy){Ph(O)NN(O)Ph}2](PF6)2 would be used as 
precatalysts for the production of acylnitroso compounds and their nitroso-ene reaction with 
alkenes. Important applications of this reaction could be in drug synthesis. An example is the 
synthesis of crinane112. Crinane is an analgesic with alkaloid derivatives112. In the synthesis of 
crinane, an acylnitroso moiety was produced and experienced a nitroso-ene reaction  
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This complex accomplishes the final apoptotic changes113. In order to determine apoptotic 
pathways the SK-HEP1 cells need to be treated with the cobalt complex, and western blot 
analysis using antibodies used to detect enzymes like cleaved caspase-8, cleaved caspase-3, and 
cleaved caspase-6113.  To learn more about the potency of the drug dose-response curves and 
measures of effective concentrations (IC50) of the SK-HEP1 cells treated with the cobalt complex 
would be performed114. A further extension of this study would be to test the cobalt complex on 
knockout mice as a part of pre-clinical studies114. 
Overall conclusion of this dissertation project 
 The hypothesis of this project involved an octahedral coordination geometry of synthesis 
of azodioxide complexes with first row transition metals (CoCl2, FeCl2, NiCl2, MnCl2, CuCl2). 
Another hypothesis was that the azodioxide complexes synthesized would be redox active. A 
third hypothesis was that the synthesized azodioxide complexes would catalyze a C-C double 
bond transposition/allylic amination reaction. A fourth hypothesis was that the synthesized 
complexes would induce apoptosis in cell-lines and would have the potential to be used as an 
anti-cancer drug. 
 For the synthesis of transition metal complexes, the only metal where successful results 
were obtained was cobalt. The coordination geometry obtained for this complex was tetragonal 
and the coordination number obtained was 8. This coordination number is very rare for cobalt 
complexes. As 6 is the common coordination number for cobalt complexes. Also trigonal 
prismatic is the common coordination geometry. Only 4 cobalt compounds with coordination 
number of eight are known in literature. For redox activity results, EPR has indicated metal –
based redox activity for the cobalt azodioxide complex. However this observation needs to be 
confirmed using cyclic voltammetry. The cobalt azodioxide complex has the ability to catalyze 
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C-C double bond transposition/ allylic amination reaction. The catalytic turnover number 
obtained was 4. The product characterization by NMR and GC-MS confirmed allylic amine 
product formation. Another nitroso-ene reaction similar to C-C double bond transposition would 
be performed using acyl nitroso compounds which would be an enantioselective reaction. 
Enantioselective reactions are useful in synthesis of active pharmaceutical ingredients. The 
cobalt azodioxide complex showed apoptosis with SK-HEP1 liver cancer cell-lines but not with 
other cancer cell-lines like- colon, breast, and lung cancer cell lines. Further pre-clinical studies 
need to be done to confirm if the cobalt azodioxide complex can act as an anticancer drug.  
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